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Summary
Structural bioinformatics is a research discipline with an ambitious goal: to move 
experiments from the real world into the computer, ex vivo in silicum, where they 
should be conducted in a faster and easier way, cost less and require the help of fewer 
animals. It is needless to say that we are still very far from reaching that goal. The ra­
tional design of drugs has not really lived up to the high expectations yet, and none of 
the major pharmaceutical companies can get away without robotic in vitro screening 
of real compounds. Why can virtual experiments not catch up with the real ones?
Most applications start with atomic models (e.g. 
an enzyme with various drug candidates bound in 
the active site) and end with a simple question: 
which model is closest to reality? If it was possible 
to answer this question reliably, one could make 
random changes to the model and arrive at the cor­
rect answer. Today, the common approach is to cal­
culate the model energies and gamble that the one 
with the lowest energy is also the most realistic 
model - just like in nature, where the configuration 
with the lowest energy is the most probable one. At 
the beginning of this thesis, we concluded that the 
main reason why this does not work well is the lim­
ited accuracy of today’s energy functions. The dif­
ference between nature’s real energy function and 
our partly empirical approximations is just too large. 
Consequently, the main goal of this thesis is to im­
prove these functions in order to arrive at more ac­
curate predictions. We focus on proteins, since they 
are the central objects of interest in structural bioin­
formatics. The straightforward way to test our 
knowledge is the “protein folding problem” -  the 
prediction of a protein structure from its amino acid 
sequence. When a prediction is already very close to 
the real structure (like in homology modeling), the 
requirements on the energy functions are maximal
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and it becomes very hard to improve the model. This “last mile of the protein folding 
problem” must be stridden before we can even hope to win the drug design challenge. 
Only if we know proteins can we try to understand their interactions.
This thesis is split in four parts: after a general introduction to protein structure 
prediction1 in chapter 1, the tools that had to be developed to do the actual research are 
described in chapter 2. These include YASARA, a molecular-graphics, -modeling and 
-simulation program2, Models@Home, a screensaver that delivers a free super­
computer by linking the PCs in a network3, and PDBFinderII4, a database to aid pro­
tein structure prediction and analysis.
Chapter 3 then introduces a new way of improving protein energy functions and 
force fields: they are allowed to parameterize themselves while energy-minimizing 
known protein structures. First this is done in vacuo to obtain the NOVA force field5, 
and then in crystal space with explicit solvent and pH-dependency6 to arrive at the 
YAMBER force fields7. All these developments have been integrated with existing 
tools like the WHAT IF program to turn a protein sequence into a three-dimensional 
model. This is achieved by ELIZA8, an expert system for protein structure prediction 
that can also incorporate experimental data, e.g. from NMR spectroscopy10-12.
Chapter 4 finally shows how ELIZA was used in close collaboration with experi­
mental research groups to answer questions of general interest: we investigated muta­
tions in the DJ-1 protein associated with parkinsonism1314, in gamma actin15 and my- 
son VIIa16 causing hearing loss, in fibroblast growth factor 14 leading to cerebellar 
ataxia17, and in p63 linked to ADULT syndrome18. In addition we modeled the interac­
tion of heparin with interleukin-89, the peroxisomal targeting signal receptor Pex5p19, 
the gastric H,K-ATPase20 and the HIV-1 receptor on dendritic cells DC-SIGN21.
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The page on the right shows a schematic repre­
sentation of proteins that helps us visualize their 
structure. Proteins are polymers of a few dozen 
to a few thousand amino acids. There are 20  
different types of amino acids, and every pro­
tein is defined by its unique sequence of amino 
acids. Interactions between the individual amino 
acids give rise to a precisely determined three­
dimensional arrangement of the polymer chain 
— the protein structure. Predicting this structure 
from the sequence of amino acids is called the 
“protein folding problem” — the topic of this 
thesis.
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Normally time-intensive experiments are re­
quired to determine a protein structure. Two 
main techniques are available: X-ray diffrac­
tion on protein crystals, and nuclear magnetic 
resonance spectroscopy. The first is very accu­
rate, but crystals can be hard to grow and pro­
tein structures may differ slightly in the crystal 
and in the living cell. The second allows to solve 
structures in their actual environment but yields 
mainly information about interatomic distances 
that must be converted to a 3D structure. This 
“embedding step” does not always work out. 
Predicting a protein structure is much faster than 
solving it experimentally, but therefore the ac­
curacy is often also much lower. This chapter 
describes how structure prediction works.
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Introduction to homology modeling
Elmar Krieger, Sander B. Nabuurs and Gert Vriend 
Methods Biochem Anal. (2003) 44:509-23.
The ultimate goal of protein modeling is to predict a structure from its sequence 
with an accuracy that is comparable to the best results achieved experimentally. This 
would allow to safely use rapidly generated in silico protein models in all the contexts 
where today only experimental structures provide a solid basis: structure-based drug 
design, analysis of protein function, interactions, or antigenic behavior, and rational 
design of proteins with increased stability or novel functions. In addition, protein 
modeling is the only way to obtain structural information if experimental techniques 
fail. Many proteins are simply too large for NMR analysis and cannot be crystallized 
for X-ray diffraction.
There are two major approaches to 3D structure prediction: one builds proteins 
from scratch, while the other one tries to modify known structures to arrive at the an­
swer. The second approach, which is the topic of this thesis, is called homology 
modeling or comparative modeling and is considerably easier. It is based on two major 
observations:
The structure of a protein is uniquely determined by its amino acid sequence1.
Knowing the sequence should at 
least in theory suffice to obtain 
the structure.
During evolution, the struc­
ture is more stable and changes 
much slower than the associated 
sequence, so that similar se­
quences adopt practically identi­
cal structures, and distantly re­
lated sequences still fold into 
similar structures. This relation­
ship was first identified by 
Chothia & Lesk2 and later quan­
tified by Sander & Schneider3. 
Thanks to the exponential growth 
of the Protein Data Bank, Rost 
could recently
Figure 1: The two zones of sequence alignments. 
Two sequences are practically guaranteed to fold 
into the same structure if their length and percent­
age sequence identity fall into the region marked as 
"safe". An example of two sequences with 150 
amino acids, 50% of which are identical, is shown 
(gray cross).
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Template sequence B (arabinose binding protein, 300 residues)
_ _____________________________ 4  - Aligned region ►____________
I n l k l g f l v k q p e e p w f q t e w k f a d k a g k d l g f e v i k i a v p d g e k t l n a i d s l a a s g a k g f v i c t p d p k l g s a i v a k a r g y d m k v i a v d D
G FEV LSIG V PEG DK SLSA VESLPASGAH GY VICTPDPRVASALV
Steps 4+5 - Loop and side chain modeling Step 3 - Backbone generation
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►Step 6 - Model optimization
Figure 2. The steps to homology modeling. The fragment of the template (arabinose binding 
protein) corresponding to the region aligned with the target sequence forms the basis of the 
model (including conserved side chains). Loops and missing side chains are predicted, then the 
model is optimized (in this case together with surrounding water molecules).
derive a more precise limit for this rule, shown in Figure 14. As long as the length of 
two sequences and the percentage of identical residues fall in the region marked as 
"safe", the two sequences are practically guaranteed to adopt a similar structure.
Imagine that we want to know the structure of sequence A (150 amino acids long, 
Figure 2). We compare sequence A to all the sequences of known structures stored in 
the PDB (using for example BLAST), and luckily find a sequence B (300 amino acids 
long) containing a region of 150 amino acids that match sequence A with 50% identi­
cal residues. As this match ("alignment") clearly falls in the safe zone (Figure 1), we 
can simply take the known structure of sequence B (the "template"), cut out the frag­
ment corresponding to the aligned region, mutate those amino acids that differ be­
tween sequences A and B, and finally arrive at our model for structure A. Structure A 
is called the "target" and is of course not known at the time of modeling.
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In practice, homology modeling is a multi-step process which can be summarized 
as follows:
•  Template recognition and initial alignment
•  Alignment correction
•  Backbone generation
•  Loop modeling
•  Side chain modeling
•  Model optimization
•  Model validation
At almost all the steps choices have to be made. The modeler can virtually never 
be sure to make the best ones, and thus a large part of the modeling process consists of 
serious thought about how to gamble between multiple seemingly similar choices. A 
lot of research has been spent on 'teaching' the computer how to make these decisions, 
so that homology models can be built fully automatically. Currently, this allows to 
construct models for about 25% of the amino acids in a genome, thereby supplement­
ing the efforts of structural genomics projects5,6. For the remaining ~75% of a genome, 
no template with a known structure is available (or cannot be detected easily), and 
one must use fold recognition , ab initio folding techniques , or simply an experiment 
to obtain structural data. While automated model building provides high throughput, 
the evaluation of these methods during CASP indicated that human expertise is still 
helpful, especially if the alignment is close to the twilight zone 7.
Step 1 - Template recognition and initial alignment
In the safe homology modeling zone (Figure 1), the percentage identity between 
the sequence of interest and a possible template is high enough to be detected with 
"simple" sequence alignment programs like BLAST8 or FASTA9.
To identify these hits, the program compares the query sequence to all the se­
quences of known structures in the PDB using mainly two matrices:
(1) A residue exchange matrix (Figure 3). The elements of this 20*20 matrix define 
the likelihood that any two of the 20 amino acids ought to be aligned. It is clearly seen 
that the values along the diagonal (representing conserved residues) are highest, but 
one can also observe that exchanges between residue types with similar physico­
chemical properties (for example F->Y) get a better score than exchanges between 
residue types that widely differ in their properties.
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C D E F G H I K L M N P Q R S T V W Y
A ' *-2 0 1 -2 0 0 -1 0 -1 0 0 1 0 -1 1 0 0 -2 -2
C - 2 -2 - 3 - 3 -2 0 -2 - 3 - 3 0 -2 - 3 - 3 -2 -1 -1 -2 -1 -2
D 0 -2 2 -2 0 1 - 3 0 -2 -1 2 0 1 -2 0 0 -2 - 3 -2
E 1 - 3 2 - 3 0 -1 -2 1 -2 -2 1 1 2 0 1 1 -1 -2 -1
F -2 - 3 -2 - 3 - 3 1 0 - 3 2 2 - 3 -2 - 3 -2 -1 -2 0 3 3
G 0 -2 0 0 - 3 -1 -2 0 -2 -2 0 0 -1 0 0 -1 -1 -2 - 3
H 0 0 1 -1 1 -1 -1 1 -1 0 1 0 1 2 0 1 -1 0 1
I -1 -2 - 3 -2 0 -2 -1 -2 2 2 -2 -2 - 3 -2 -1 0 2 0 0
K 0 - 3 0 1 - 3 0 1 -2 -1 -2 1 0 1 2 0 0 -1 -2 -2
L -1 - 3 -2 -2 2 -2 -1 2 -1 3 -2 -2 0 -1 -1 0 2 0 0
M 0 0 -1 -2 2 -2 0 2 -2 3 -1 -2 0 -2 -1 0 1 -2 -1
N 0 -2 2 1 - 3 0 1 -2 1 -2 -1 -2 1 0 2 0 -2 - 3 -1
P 1 - 3 0 1 -2 0 0 -2 0 -2 -2 -2 0 0 0 0 -1 - 3 - 3
Q 0 - 3 1 2 - 3 -1 1 - 3 1 0 0 1 0 2 1 0 -1 -1 -2
R -1 -2 -2 0 -2 0 2 -2 2 -1 -2 0 0 2 1 0 -1 0 -1
S 1 -1 0 1 -1 0 0 -1 0 -1 -1 2 0 1 1 2 -1 0 0
T 0 -1 0 1 -2 -1 1 0 0 0 0 0 0 0 0 2 0 -1 -2
V 0 -2 -2 -1 0 -1 -1 2 -1 2 1 -2 -1 -1 -1 -1 0 -1 0
W -2 -1 - 3 -2 3 -2 0 0 -2 0 -2 - 3 - 3 -1 0 0 -1 -1 3
Y -2 -2 -2 -1 3 - 3 1 0 -2 0 -1 -1 - 3 -2 -1 0 -2 0 3
Figure 3: A typical residue exchange or scoring matrix used by alignment algorithms. Because 
the score for aligning residues A and B is normally the same as for B and A, this matrix is 
symmetric.
(2) An alignment matrix (Figure 4). The axes of this matrix correspond to the two 
sequences to align, and the matrix elements are simply the values from the residue 
exchange matrix (Figure 3) for a given pair of residues. During the alignment process, 
one tries to find the best path through this matrix, starting from a point near the top 
left, and going down to the bottom right. To make sure that no residue is used twice, 
one must always take at least one step to the right and one step down. A typical align­
ment path is shown in Figure 4. At first sight, the dashed path in the bottom right cor­
ner would have led to a higher score. However, it requires to open an additional gap in 
sequence A (Gly of sequence B is skipped). By comparing thousands of sequences and 
sequence families, it became clear that the opening of gaps is about as unlikely as at 
least a couple of non-identical residues in a row. The jump roughly in the middle of 
the matrix on the other hand is justified, because after the jump we earn lots of points 
(5,6,5) which would have been (1,0,0) without the jump. The alignment algorithm 
therefore subtracts an "opening penalty" for every new gap and a much smaller "gap 
extension penalty" for every residue that is skipped in the alignment. The gap exten­
sion penalty is smaller simply because one gap of three residues is much more likely 
than three gaps of one residue each.
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V A T T P D K S W L T V
A 0 5 0 0 1 0 0 1 -2 -1 0 0
S -1 1 2 2 0 0 0 5 0 -1 2 -1 Sequence A:
T 0 0 5 5 0 0 0 2 -1 0 5 0 VATTPDKSWLTV
P -1 1 0 0 8 0 0 0 -3 -2 0 -1 Sequence B:
E -2 1 1 1 1 2 1 1 -2 -2 1 -1 ASTPERASWLGTA
R -1 -1 0 0 0 -2 2 1 0 -1 0 -1 1
A 0 5 0 0 1 0 0 1 -2 -1 0 0
S -1 1 2 2 0 0 0 5 0 -1 2 -1 ▼
W -1 -2 -1 -1 -3 -3 -2 0 6 0 -1 -1 VATTPDK-SWLTV-
L 2 -1 0 0 -2 -2 -1 -1 0 5 0 2 |*||** |||
G -1 0 -1 -1 0 0 0 0 -2 -2 -1 -1 -ASTPERASWLGTA
T 0 0 5 5 0 0 0 2 -1 0 x 5 0
A 0 5 0 0 1 0 0 1 -2 -1 0 X 0
Figure 4: The alignment matrix for the sequences VATTPDKSWLTV and ASTPERASWL- 
GTA, using the scores from Figure 3. The optimum path corresponding to the alignment on the 
right side is shown in gray. Residues with similar properties are marked with a star '*'. The 
dashed line marks an alternative alignment that scores more points but requires to open a sec­
ond gap.
In practice, one just feeds the query sequence to one of the countless BLAST 
servers on the web, selects to search the PDB, and obtains a list of hits - the modeling 
templates and corresponding alignments (Figure 2).
Step 2 - Alignment correction
Having identified one or more possible modeling templates using the fast methods 
described above, it is time to consider more sophisticated methods to arrive at a better 
alignment.
Sometimes it may be difficult to align two sequences in a region where the per­
centage sequence identity is very low. One can then use other sequences from ho­
mologous proteins to find a solution. A pathological example is shown in Figure 5: 
suppose you want to align the sequence LTLTLTLT with YAYAYAYAY. There are 
two equally poor possibilities, and only a third sequence, TYTYTYTYT, which aligns 
easily to both of them can solve the issue.
The example above introduced a very powerful concept called "multiple sequence 
alignment". Many programs are available to align a bunch of related sequences, for 
example CLUSTALW10, and the resulting alignment contains a lot additional informa­
tion. Think about an Ala->Glu mutation. Relying on the matrix in Figure 3, this ex­
change always gets a score of 1. In the three dimensional structure of the protein, it is
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however very unlikely to see such an Ala->Glu exchange in the hydrophobic core, but 
on the surface this mutation is perfectly normal. The multiple sequence alignment im­
plicitly contains information about this structural context. If at a certain position only 
exchanges between hydrophobic residues are observed, it is highly likely that this 
residue is buried. To consider this knowledge during the alignment, one uses the mul­
tiple sequence alignment to derive position specific scoring matrices, also called "pro­
files"1112.
Figure 5: A pathological alignment problem. Sequences A and B are impossible to align, unless 
one considers a third sequence C from a homologous protein.
Template 
Model(bad) 1 
Model(good) 2
Figure 6. Example of a sequence alignment where a three-residue deletion must be modeled. 
While the first alignment appears better when considering just the sequences (a matching 
proline at position 7), a look at the structure of the template leads to a different conclusion 
(Figure 7).
When building a homology model, we are in the fortunate situation of having an 
almost perfect profile - the known structure of the template. We simply know that a 
certain alanine sits in the protein core and must therefore not be aligned with a gluta­
mate. Multiple sequence alignments are nevertheless useful in homology modeling, 
for example to place deletions (missing residues in the model) or insertions (additional 
residues in the model) only in areas where the sequences are strongly divergent. A 
typical example for correcting an alignment with the help of the template is shown in 
Figures 6 and 7. While a simple sequence alignment gives the highest score for the 
wrong answer (alignment 1 in Figure 6), a simple look at the structure of the template
1 2 3___4___5___6___7___8___9___10 11 12 13
PHE ASP ILE CYS ARG LEU PRO GLY SER ALA GLU ALA VAL
PHE ASN VAL CYS ARG ALA PRO GLU ALA ILE
PHE ASN VAL CYS ARG -- ALA PRO GLU ALA ILE
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reveals that alignment 2 is correct, because it leads to a small gap, compared to a huge 
hole associated with alignment 1.
Figure 7. Correcting an alignment 
based on the structure of the model­
ing template (Ca-trace shown in 
black). While the alignment with the 
highest score (dark gray, also in 
Figure 6) leads to a gap of 7.5A 
between residues 7 and 11, the sec­
ond option (white) creates only a 
tiny hole of 1.3A between residues 5 
and 9. This can easily be accommo­
dated by small backbone shifts. 
(The normal Ca-Ca distance of 
3.8A has been subtracted).
Step 3 - Backbone generation
When the alignment is ready, the actual model building can start. Creating the 
backbone is trivial for most of the model: one simply copies the coordinates of those 
template residues that show up in the alignment with the model sequence (Figure 2). If 
two aligned residues differ, only the backbone coordinates (N,CA,C and O) can be 
copied. If they are the same, one can also include the side chain (at least for not too 
flexible side chains, rotamers tend to be conserved).
Experimentally determined protein structures are not perfect (but still better than 
models in most cases). There are countless sources of errors, ranging from poor elec­
tron density in the X-ray diffraction map to simple human errors when preparing the 
PDB file for submission. A lot of work has been spent on writing software to detect 
these errors (correcting them is even harder), and the current count is at more than 
10.000.000 problems in the 17.000 structures deposited in the PDB by the end of 
2001. It is obvious that a straightforward way to build a good model is to choose the 
template with the fewest errors (the PDBREPORT database13 at 
www.cmbi.kun.nl/gv/pdbreport can be very helpful). But what if two templates are 
available, and each has a poorly determined region, but these regions are not the 
same? One should clearly combine the good parts of both templates in one model - an 
approach known as "multiple template modeling". (The same applies if the alignments 
between the model sequence and possible templates show good matches in different 
regions). Although in principle simple (and done by automated modeling servers like 
Swiss-Model6), it is hard in practice to achieve results that are really closer to the true 
structure than all the templates.
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Step 4 - Loop modeling
In the majority of cases, the alignment between model and template sequence 
contains gaps. Either gaps in the model sequence (deletions as shown in Figures 6 and 
7) or in the template sequence (insertions). In the first case one simply omits residues 
from the template, creating a hole in the model that must be closed. In the second case, 
one takes the continuous backbone from the template, cuts it, and inserts the missing 
residues. Both cases imply a conformational change of the backbone. The good news 
is that conformational changes cannot happen within regular secondary structure ele­
ments. It is therefore safe to shift all insertions or deletions in the alignment out of 
helices and strands, placing them in loops and turns. The bad news is that these 
changes in loop conformation are notoriously hard to predict (the big unsolved prob­
lem in homology modeling). To make things worse, even without insertions or dele­
tions do we often find quite different loop conformations in template and target. Three 
main reasons can be identified (Rodriguez, http://www.cmbi.kun.nl/gv/articles/text/ 
gambling.html):
•  Surface loops tend to be involved in crystal contacts, leading to a significant con­
formational change between template and target.
•  The exchange of small to bulky side chains underneath the loop pushes it aside.
•  The mutation of a loop residue to proline or from glycine to any other residue. In 
both cases, the new residue must fit into a more restricted area in the Ramachandran 
plot, which most of the time requires conformational changes of the loop.
There are two main approaches to loop modeling:
(1) Knowledge based: one searches the PDB for known loops with endpoints that 
match the residues between which the loop has to be inserted, and simply copies the 
loop conformation. All major molecular modeling programs and servers support this 
approach (e.g. 3D-Jigsaw14, Insight15, Modeller16, Swiss-Model6 or WHAT IF17).
(2) Energy based: as in true ab initio fold prediction, an energy function is used to 
judge the quality of a loop. Then this function is minimized, using Monte Carlo18 or 
molecular dynamics techniques19 to arrive at the "best" loop conformation. Often the 
energy function is modified ("smoothed") to facilitate the search20.
At least for short loops (up to 5-8 residues), the various methods have a reason­
able chance of predicting a loop conformation that superposes well on the true struc­
ture. As mentioned above, surface loops tend to change their conformation due to 
crystal contacts. So if the prediction is made for an isolated protein and then found to 
differ from the crystal structure, it might still be correct.
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Step 5 - Side chain modeling
When we compare the side chain conformations ("rotamers") of residues that are 
conserved in structurally similar proteins, we find that they often have similar Xi- 
angles (i.e. the torsion angle about the Ca-Cp bond). It is therefore possible to simply 
copy conserved residues entirely from the template to the model (see also step 3) and 
achieve a higher accuracy than by copying just the backbone and re-predicting the side 
chains. In practice, this rule of thumb holds only at high levels of sequence identity, 
when the conserved residues form networks of contacts. When they get isolated 
(<35% sequence identity), the rotamers of conserved residues may differ in up to 45% 
of the cases21.
Practically all successful approaches to side chain placement are at least partly 
knowledge based: They use libraries of common rotamers, extracted from high resolu­
tion X-ray structures. The various rotamers are tried successively and scored with a 
variety of energy functions. Intuitively, one might expect rotamer prediction to be 
computationally demanding due to the "combinatorial explosion": The choice of a 
certain rotamer automatically affects the rotamers of all neighboring residues, which 
in turn affect their neighbors and so on. With 100 residues and on average ~5 rotamers 
per residue, one would already end up at 5100 different combinations to score - that's 
about a 1 with 70 zeros. A lot of research has been spent on the development of meth­
ods to make this enormous search space tractable22. The number of combinations is in 
fact so large, that even nature could not try all of them during the folding process. This 
already indicates that there must exist mechanisms to shrink down the search-space.
Beside the trivial fact that 
copying conserved rotamers 
from the template often splits up 
the protein into distinct regions 
where rotamers can be predicted 
independently, the key to han­
dling the "combinatorial explo­
sion" lies in the protein back­
bone: Certain backbone confor­
mations strongly favor certain 
rotamers (allowing for example a 
hydrogen bond between side 
chain and backbone) and thus 
greatly reduce the search-space. 
For a given backbone conforma­
Figure 8: Example of a backbone-dependent rotamer 
library. The current backbone conformation (space­
filling display) favors two different rotamers for 
Tyrosine (sticks) which appear about equally often 
in the database.
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tion, there may be only one strongly populated rotamer which can be modeled right 
away, thereby providing an anchor for surrounding, more flexible side chains. An ex­
ample for a backbone conformation that favors two different tyrosine rotamers is 
shown in Figure 8. These "position-specific rotamer libraries" are widely used today23- 
25. To build such a library, one takes high resolution structures and collects all 
stretches of 3 to 7 residues (depending on the method) with a given amino acid in the 
center. To predict a rotamer, the corresponding backbone stretch in the template is 
superposed on all the collected examples, and the possible side chain conformations 
are selected from the best backbone matches26.
Further evidence that the combinatorial problem of rotamer prediction is far 
smaller than originally believed was found recently: Xiang and Honig first removed 
one single side chain from known structures and re-predicted it. In a second step, they 
removed all the side chains and added them again using the same simple search strat­
egy. Surprisingly, it turned out that the accuracy was only marginally higher in the 
much easier first case27.
The prediction accuracy is usually quite high for residues in the hydrophobic core 
where >90% of all x1-angles fall within ±20° from the experimental values, but much 
lower for residues on the surface where the percentage is often even below 50%. There 
are two reasons for that:
(1) Experimental reasons: flexible side chains on the surface tend to adopt multiple 
conformations, which are additionally influenced by crystal contacts. So even experi­
ment cannot provide one single "correct answer".
(2) Theoretical reasons: the energy functions used to score rotamers can easily han­
dle the hydrophobic packing in the core (mainly Van der Waals interactions), but are 
not accurate enough to get the complicated electrostatic interactions on the surface 
right, including hydrogen bonds with water molecules and associated entropic effects.
It is important to note that the prediction accuracies given in most publications 
cannot be reached in real-life applications. This is simply due to the fact that the 
methods are evaluated by taking a known structure, removing the side chains and re- 
predicting them. The algorithms thus rely on the "correct" backbone, which is not 
available in homology modeling: the backbone of the template often differs signifi­
cantly from the target. The rotamers must thus be predicted based on a "wrong" back­
bone - and prediction accuracies tend to be lower in this case.
Step 6 - Model Optimization
The problem just mentioned above leads to a classical "chicken and egg" situa­
tion: to predict the side chain rotamers with high accuracy, we need the correct back­
bone, which in turn depends on the rotamers and their packing. The common approach
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to such a problem is an iterative one: predict the rotamers, then the resulting shifts in 
the backbone, then the rotamers for the new backbone, and so on, until the procedure 
converges. This boils down to a sequence of rotamer prediction and energy minimiza­
tion steps. The latter use the methods from the loop modeling step above, but this time 
they must be applied to the entire protein structure, not just an isolated loop. This re­
quires an enormous accuracy in the energy function, because there are many more 
paths leading away from the answer (the target structure) than towards it. That is why
energy minimization must be 
used carefully. At every minimi­
zation step, a few big errors (like 
"bumps", i.e. too short atomic 
distances) are removed while at 
the same time many small errors 
are introduced. When the big 
errors are gone, the small ones 
start accumulating and the model 
moves away from the target 
(Figure 9). As a rule of thumb, 
today's modeling programs 
therefore either restrain the atom 
positions and/or apply only a few 
hundred steps of energy minimi­
zation. In short, model optimiza­
tion does not work until energy 
functions ("force fields") get 
more accurate. Two ways to 
achieve that are currently being 
pursued:
(1) Quantum force fields: protein force fields must be fast to handle these large 
molecules efficiently, energies are therefore normally expressed as a function of the 
positions of the atomic nuclei only. The continuous increase of computer power has 
now finally made it possible to apply methods of quantum chemistry to entire proteins, 
arriving at more accurate descriptions of the charge distribution28. It is however still 
difficult to overcome the inherent approximations of today's quantum chemical calcu­
lations. Attractive Van der Waals forces are for example so hard to treat, that they 
must often be completely omitted. While providing more accurate electrostatics, the 
overall accuracy achieved is still about the same as in the "classical" force fields.
Energy minimization of homology models
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Figure 9: The average RMSD between models and 
targets during an extensive energy minimization of 
14 homology models with two different force fields. 
Both force fields improve the models during the first 
~500 energy minimization steps but then the small 
errors sum up in the classic force field and guide the 
minimization in the wrong direction, away from the 
target while the self-parameterizing force field goes 
in the right direction. To reach experimental accu­
racy, the minimization would have to proceed all the 
way down to ~0.5 A which is the uncertainty in ex­
perimentally determined coordinates.
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(2) Self-parameterizing force fields: the accuracy of a force field depends to a large 
extent on its parameters (e.g. Van der Waals radii, atomic charges). These parameters 
are usually obtained from quantum chemical calculations on small molecules and fit­
ting to experimental data, following elaborate rules29. By applying the force field to 
proteins, one implicitly assumes that a peptide chain is just the sum of its individual 
small molecule building blocks - the amino acids. Alternatively, one can just state a 
goal - e.g. "improve the models during an energy minimization" - and then let the 
force field "parameterize itself" while trying to optimally fulfill this goal30. This leads 
to a computationally rather expensive procedure: Take initial parameters (for example 
from an existing force field), change a parameter randomly, energy minimize models, 
see if  the result improved, keep the new force field if  yes, otherwise go back to the 
previous force field. With this procedure, the force field accuracy increases enough to 
go into the right direction during an energy minimization (Figure 9), but experimental 
accuracy is still far out of reach.
The most straightforward approach to model optimization is to simply run a mo­
lecular dynamics simulation of the model. Such a simulation follows the motions of 
the protein on a femtosecond (10-15 s) timescale and mimics the true folding process. 
One thus hopes that the model will complete its folding and "home in" to the true 
structure during the simulation. The advantage is that a molecular dynamics simula­
tion implicitly contains entropic effects that are otherwise hard to treat, the disadvan­
tage is that the force fields are again not accurate enough to make it work. (One must 
in fact be happy if the model is not "messed up" during the simulation). Nevertheless, 
one of the main tasks of Blue Gene, the forthcoming "fastest computer in the world", 
will be to run exactly this type of molecular dynamics simulations31. More accurate 
force fields will have to be available when Blue Gene goes online...
Step 7 - Model Validation
Every homology model contains errors. The number of errors (for a given 
method) depends on mainly two values:
(1) The number of errors in the template.
(2) The percentage sequence identity between template and target. If it is greater 
than 90%, the accuracy of the model can be compared to crystallographically deter­
mined structures, except for a few individual side chains 2’32. From 90% down to 50% 
identity, the RMS error in the modeled coordinates can be as large as 1.5 A, with con­
siderably larger local errors. If the sequence identity drops to 25%, the alignment 
turns out to be the main bottleneck for homology modeling, leading to often very large 
errors.
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As with most errors, they become less of a problem when they can be localized. 
Upon modeling a protease it is probably not important that a loop far away from the 
active site is placed incorrectly. The essential step in the homology modeling process 
is therefore undoubtedly the verification of the model, and the estimation of the likeli­
hood, magnitude and location of errors.
There are two principally different ways to estimate errors in a structure:
(1) Calculating the model’s energy based on a molecular dynamics force field: 
This allows to check if the bond lengths and bond angles are within normal ranges, 
and if  there are lots of bumps in the model (corresponding to a high Van der Waals 
energy). Truly essential questions like "is the model folded correctly?" cannot be an­
swered this way, because completely misfolded but well minimized models often 
reach the same force field energy as the target structure33. This is due to the fact that 
molecular dynamics force fields do not explicitly contain entropic terms (like hydro­
phobic interactions), but rely on the simulation to generate them. While this problem 
can be addressed by extending the force field and adding e.g. solvation terms34 or 
know-ledge-based potentials31, the major drawback is that one always obtains a single 
number for the entire protein and cannot trace problems down to individual residues.
(2) Determination of normality indices that describe how well a given characteristic 
of the model resembles the same characteristic in real structures. Many features of 
protein structures are well suited for normality analysis. Most of them are directly or 
indirectly based on the analysis of contacts, either inter-residue contacts, or contacts 
with water. Some published examples are:
•  General checks for the normality of bond lengths, bond- and torsion angles35,36 are 
good checks for the quality of experimentally determined structures, but are less suit­
able for the evaluation of models because the better model building programs simply 
do not make this kind of errors.
•  Inside/outside distributions of polar and apolar residues can be used to detect 
completely misfolded models37.
•  Packing rules have been derived for structure evaluation38.
•  Atomic contacts that are not abundant in the protein structure database are good 
indicators of local model building problems39. If a contact between two residue frag­
ments has the same distance and orientation as a contact that occurs often in the data­
base of known structures, then a high score is given. If a contact in the model seems 
rather unique, a low score is given. This 'quality control' of local packing has proven 
to be a powerful tool for the detection of abnormal structures.
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Most methods used for the verification of models can also be applied to experi­
mental structures (and hence the templates used for model building). A detailed veri­
fication is essential when trying to derive new information from the model, either to 
interpret or predict experimental results or plan new experiments.
As a summary, it is safe to say that homology modeling is unfortunately not as 
easy as stated in the beginning. Ideally, homology modeling uses threading to improve 
the alignment, ab initio folding to predict the loops and molecular dynamics simula­
tions with a perfect force field to home in to the "true" structure. Doing all that cor­
rectly will keep researchers busy for a long time, leaving lots of fascinating discover­
ies to good old experiment.
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Protein structure prediction is not like theoretical 
physics -  where good ideas and some formulas 
can win the day. Instead it is always tightly 
coupled with extensive software development. 
Huge amounts of code have to be written be­
fore a new hypothesis can be tested. This chap­
ter describes the essential base on which this 
thesis is built: YASARA, a molecular graphics, 
modeling and simulation program; the Twinset, 
a FORTRAN/C interface that unites YASARA 
with the WHAT IF program; PVL, a compiler for 
portable high performance computing; Mod- 
els@Home, a distributed computing system that 
turns a network of workstations into a uniform 
cluster; and the PDBFINDER2, a database for 
structure prediction and analysis.
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The Tools
33
Protein structures that have been solved ex­
perimentally are deposited at the Protein Data 
Bank (www.pdb.org), where they are stored in 
flat text files called “PDB files”. A PDB file con­
tains the Cartesian coordinates of the protein 
atoms, residue names and numbers, and a lot of 
additional information about the experiment, 
literature references etc. Before one can really 
work with the proteins, the PDB file has to be 
parsed and converted to a three-dimensional 
representation of the protein. This is just one 
function of YASARA, a molecular modeling and 
simulation program that took over 1 0 years to 
develop and was used extensively together 
with Gert Vriend’s WHAT IF program during 
this thesis.
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How to solve the molecular 
visualization problem
Abstract
Because our brain prefers images over numbers, progress in the natural sciences is 
coupled with the ability to display and investigate molecules on a computer screen. 
Nowadays, computers are equipped with graphics processing units (GPUs), that heav­
ily accelerate the display of three-dimensional models. Molecular visualization algo­
rithms run into an unexpected problem, however: GPUs are highly optimized for 
drawing triangles, while atoms are typically shown as plain spheres. Programmers are 
thus forced to join ~320 or more triangles to display one single atom. For large bio- 
molecular systems with tens of thousands of atoms, this approach becomes prohibi­
tively slow. Here I describe a novel way of drawing molecules, that requires a mini­
mum number of two triangles per atom. These flat triangles have a precalculated im­
age of a sphere attached which creates the illusion of depth. When compared with the 
classical approach, the novel method is up to 35 times faster, especially when visualiz­
ing large structures like the ribosome or virus capsides. An implementation of the al­
gorithm is freely available as part of YASARA, a molecular graphics, modeling and 
simulation program for Linux and Windows, with support for structure analysis and 
prediction, interactive real-time simulations, molecular animations, flexible morphing, 
movies, multimedia presentations, Python plugins and Yanaconda macros at 
www.yasara.org.
Introduction
Since Cyrus Levinthal pioneered molecular graphics in 1966 at the MIT, when he 
set up the first interactive wire-frame display of a protein on a monochrome oscillo- 
scope1, the development has closely followed the exponential growth of computer 
power. While the field was initially dominated by expensive specialized solutions, 
personal computers could finally catch up in the 1990s, delivering “molecular graphics 
for all” thanks to fast drawing algorithms used e.g. by Rasmol2. Around the year 2000, 
it became common standard to equip personal computers with specialized graphics 
processing units (GPUs) that provide functions to visualize three-dimensional scenes, 
easily accessible via the OpenGL programming interface. The high quality of these
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graphics caused a move away from purely software-based2 towards hardware- 
accelerated drawing algorithms3,4, that are unfortunately faced with the “molecular 
visualization problem”: GPUs are designed for drawing triangles covered by images 
called textures, while atoms are typically shown as simple spheres. Building a sphere 
from triangles is hard work, around ~1000 triangles must be joined to display one sin­
gle water molecule (Figure 1A). For large biomolecular systems with tens of thou­
sands of atoms, this approach becomes too slow for interactive visualization, and one 
has to switch to a simple wire-frame style or a higher abstraction level that indicates 
just the secondary structure using e.g. a ribbon.
Figure 1 : Two ways o f drawing molecules. The classical approach (A) requires 960 triangles 
to display a reasonably round water molecule, while just 14 are needed by the new algorithm in 
the example shown on the right (B).
The proposed solution is depicted in Figure 1B. One aims at using only two trian­
gles per atom, that are covered by a precalculated image of a sphere. The image is 
transparent at the four corners. There is a good reason why this idea has not been im­
plemented before: ‘atoms’ consisting of two triangles are just flat squares, that will 
never intersect like true spheres. This issue can be resolved by looking at chemical 
bonds to more distant atoms (i.e. atoms with a larger Z-coordinate). Hydrogen 1 does 
not have any (the oxygen is closer), so it can be drawn with two triangles. The oxygen 
has one critical bond to hydrogen 1, but the Z-distance is larger than the sphere radius 
of the hydrogen, so there cannot be a visible intersection - and consequently it can be
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drawn quickly too. Hydrogen 2 also has one critical bond, and this time the intersec­
tion curve with the oxygen must be calculated. For simplicity, this is not done analyti­
cally, but by comparing precalculated depth values of the two sphere images. Then a 
number of smaller triangles is drawn such that only the truly visible parts of hydrogen
2 appear on screen. In this example, just 14 instead of 960 triangles are required to 
show a water molecule.
Methods
When compared to the classical approach, the algorithm described here requires 
considerably more calculations, which are too specific for the GPU and have to be 
done by the system’s main processor. E.g. all atoms must be transformed to screen 
coordinates to determine the sphere intersection curves (which has the advantage that 
off-screen atoms can immediately be skipped). To minimize the impact of the surplus 
computations, considerable efforts were spent on the development of PVL, the Port­
able Vector Language. PVL allows to work with vectors of arbitrary length in a port­
able way. The PVL compiler creates different code paths for each CPU architecture to 
make optimal use of the various vector instruction sets that have been introduced dur­
ing the past 7 years (MMX, 3DNow!, SSE, SSE2) and can hardly be exploited by a 
normal C or Fortran compiler.
Results
A new way of drawing molecules
Figure 2 shows screenshots of the three main visualization styles produced by the 
new algorithm. In space filling mode (A), the spheres intersect and the calculations 
described in the introduction have to be carried out. In ball&stick (B) and stick (C) 
mode, the spheres never intersect and can always be drawn using just two triangles. 
The sticks themselves are added in the end, requiring between 2 and 16 triangles per 
stick, depending on the distance of the atom from the viewer (level of detail) and the 
colors of the joined atoms (if they differ, the stick has to be drawn in two parts). The 
implementation of stereo graphics is also straightforward: two precalculated images 
are used that show the spheres from slightly different points of view, corresponding to 
the left and right eye.
The new approach was found to be 35 times faster when visualizing the large ri- 
bosomal subunit with ~ 100000 atoms (PDB entry 1N8R). The visual quality is also 
higher, as spheres are always perfectly round and can easily be antialiased (if the pre­
calculated sphere image contains a smooth border and the atoms are sorted by their Z- 
distance before drawing). The algorithm does not require any additional set-up time
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for the geometry, and is thus equally fast if the atom coordinates change continuously, 
for example when showing a molecular dynamics simulation in real-time.
180 Hz|M an9jjBPK I | VRSRRR Mms/him. |  Obj all | Sim Off I 981 Atoms
Figure 2: YASARA screenshot showing the three main styles of all-atom molecular graphics. 
Space filling (A), ball & stick (B) and plain sticks (C).
YASARA -  Yet Another Scientific Artificial Reality Application
The algorithm described here forms the basis on which YASARA is built, a mo­
lecular graphics, -modeling and simulation program for Linux and Windows with sup­
port for shutter glasses, autostereoscopic displays and special input devices like data 
gloves. Central features include publication quality ray-traced images including labels 
and arrows, molecular simulations with well known (AMBER5) and newly developed 
force fields (NOVA6, YAMBER), structure analysis, determination and prediction, the 
Y anaconda macro language for complicated tasks, Plugins written in Python, interac­
tive tutorials, molecular movies and presentations. The initial stage YASARA View is 
freely available from www.yasara.org.
Acknowledgements: YASARA would not exists in its present form without the truly appreci­
ated support of Günther Koraimann, Andreas Kungl and Gert Vriend. I would also like to 
thank all YASARA users for providing essential feedback.
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Molecular modeling often involves a  perform­
ance/accuracy trade-off. The higher the 
level/accuracy/flexibility of the computations, 
the longer it takes to complete them. E.g. in ho­
mology modeling it often helps to build multiple 
models from different templates and align­
ments. Model refinement using molecular d y ­
namics simulations also takes a  long time. Con­
sequently a  normal desktop PC is not enough to 
finish the task in time. One possible solution is to 
buy an expensive supercomputer. Another one 
is to link those PCs that a re  already  present 
and use them when their owners sleep@home. 
This approach is described in the following 
chapter.
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Models@Home: distributed computing 
in bioinformatics using a 
screensaver based approach
Elmar Krieger and Gert Vriend 
Bioinformatics. (2002) 18:315-8.
Abstract
Motivation: Due to the steadily growing computational demands in bioinformatics 
and related scientific disciplines, one is forced to make optimal use of the available 
resources. A straightforward solution is to build a network of idle computers and let 
each of them work on a small piece of a scientific challenge, as done by Seti@Home, 
the world's largest distributed computing project.
Results: We developed a generally applicable distributed computing solution that uses 
a screensaver system similar to Seti@Home. The software exploits the coarse-grained 
nature of typical bioinformatics projects. Three major considerations for the design 
were: 1) Often, many different programs are needed, while the time is lacking to paral­
lelize them. Models@Home can run any program in parallel without modifications to 
the source code. 2) In contrast to the Seti project, bioinformatics applications normally 
are more sensitive to lost jobs. Models@Home therefore includes stringent control 
over job scheduling. 3) To allow use in heterogeneous environments, Linux and Win­
dows based workstations can be combined with dedicated PCs to build a homogene­
ous cluster. We present three practical applications of Models@Home, running the 
modeling programs WHAT IF and YASARA on 30 PCs: Force field parameterization, 
molecular dynamics docking, and database maintenance.
Availability: Models@Home is freely available including source code and detailed 
instructions from http://www.yasara.org/models.
Introduction
No matter how smart the algorithm, it is always too slow to do the job - overnight 
on a desktop PC. And when PCs have finally become fast enough - the algorithm has 
become obsolete, replaced by a new approach, with fewer approximations. That is a 
well known experience in bioinformatics, almost comparable to Murphy's law. The 
usual approach is to split the problem into little jobs that can be executed independ­
ently. The execution time is then reduced by 1/n, with n being the number of com­
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puters working in parallel. As noted by Amdahl1, this ideal speedup cannot be reached 
in practice, leading to the more realistic formulation
Sn ( 1 - PF ) + PF / An (1)
in which Sn it the the total speedup when going from one to n processors, PF is the 
"parallelizable fraction" of the program (i.e. the fraction of the total execution time 
that can be reduced by working in parallel), and An is the speedup of the algorithm's 
PF on n processors.
Algorithms in bioinformatics tend to be applied to a large number of different tar­
gets, e.g. all ORFs in a genome, all sequences in CASP, or all potential drug candi­
dates in a library. If each computer is assigned one target, these jobs are completely 
independent and parallelize perfectly, as no communication overhead is required: PF 
is close to one, An and Sn are close to n. The coarse-grained nature of typical bioin­
formatics projects is probably one of the reasons why most follow-ups to Seti@Home 
fall into this area, e.g. FightAids@Home or Folding@Home. An overview of other 
approaches to distributed computing, clusters and computational grids is given in table 
1.
Program name www Address S O W U Description
Beowulf www.beowulf. org + + - + Software for dedicated Linux clusters
Berkeley NOW now.cs.berkeley. edu + + - + Inhouse network of workstations
Condor www.cs.wisc.edu/condo
r
+ + + + Distributed computing library
Cosm www.mithral.com + + + + Distributed computing library
Distributed.net www.distributed.net - - + + Cracking encryption keys
Entropia www.entropia.com - $ + - Distributed computing for Windows
F ightAids@Home www. fightaidsathome. c 
om
- - + - Drug design using Entropia
Folding@Home www.stanford.edu/grou 
p/ pandegroup/Cosm
- - + - Protein folding simulations using 
Cosm
Globus Project www.globus.org + + - + Computational grid for Unix
Legion legion.virginia.edu - + - + Worldwide computer for Unix
Models@Home www.y asara. org/models + + + + Screensaver cluster for any program
Mo six www.mosix.cs.huji.ac.il + + - + Software for dedicated Linux clusters
Seti@Home setiathome. berkeley. edu - - + + Search for extraterrestrial intelligence
United Devices www.ud.com - $ + - Distributed computing for Windows
Table 1: List of different approaches to clusters and distributed computing. S = source code 
available, O = run your own programs ($ requires payment), W = available for Windows, U = 
available for Unix/Linux.
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Methods
Models@Home has been designed for use in typical departmental situations, in 
which a large number of Linux or Windows workstations is idle for about 16 hours a 
day. The program consists of several functional units, as shown in figure 1. Detailed 
installation instructions are available from http://www.yasara.org/models.
Supervisors
Users of the cluster run programs called "supervisors". These are typically appli­
cations that keep track of the work that has to be done, but do not do it themselves. 
Instead they cut it into pieces and submit the individual jobs to the Models@Home job 
scheduler (via an interface of C functions or a Python class). The supervisors thus 
form the part that has to be adapted specifically for a certain application. This is most 
easily done by adding a "submit to Models@Home"-command to the inner loop of an 
existing script. All other aspects of Models@Home are totally general.
Working Clients
As the name suggests, they do the actual work. Initially, only the Idle Detection 
(ID) module is active on these computers. The ID module is highly operating system 
specific and has been derived from existing open-source screensavers. The Linux ver­
sion is based on Jamie Zawinski's XScreensaver (www.jwz.org/xscreensaver), with 
additional changes to Linux configuration files, the Windows equivalent on Bill 
Buckel's work (www.escape.ca/~bbuckels). The modified sources are available from
Figure 1: Models@Home data flow. Refer to the methods section for details. Abbreviations: ID 
= Idle Detection module, Exec = Program execution module, ScrSaver = graphical screensaver 
module, App 1+2 = application 1+2, TCP/IP = Transmission Control Protocol / Internet Proto­
col, NFS = Network File System.
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As soon as the computer is idle (i.e. no mouse movements or key-strokes occur 
for 15 minutes), the ID module launches a graphical screensaver (ScrSaver) and the 
execution module (Exec). Both have been implemented in an operating-system inde­
pendent way based on the SDL library, including SDL_net for the TCP/IP interface 
(www.libsdl.org). Users running batch jobs can configure the screensaver to become 
active only if they are not logged in.
The Exec module contacts the server. This contact message also contains the time 
stamps of files that should be kept up to date (these names are stored with other infor­
mation, like the server's IP address, in the local configuration file "cluster.cnf').
If there are jobs waiting in the queue, the Exec module receives a job description 
(the name of the application to run, command line parameters, scripts), file updates if 
needed, and the data files required to complete the job (e.g. specific PDB files). These 
are stored in the working directory /job. Exec runs the requested application (App 1 or 
App 2 in figure 1) and waits until the job has finished. Result files are sent back to the 
server. Large applications consisting of hundreds of files should be permanently in­
stalled on the clients, small and compact programs can be transmitted as part of the job 
description.
If a user on a working client terminates the screensaver, Exec kills the running 
application and notifies the server that the job could not be completed. No attempt is 
made to put the application on hold and continue at a later time, as this would nega­
tively affect the cluster's performance (it is not known if and when the client will be 
available again). Jobs taking a long time must therefore return checkpoint files in rea­
sonable time intervals. Usually this does not require a modification of the source code, 
as most time-intensive programs already have these mechanisms built in (e.g. every 
molecular dynamics program can save a snapshot of the current simulation state).
Exec can also be run as a stand-alone module (without the screensaver) on the 
nodes of a dedicated cluster. It then allows a very efficient use of cluster resources: 
While many batch queuing systems generate the maximum overhead when the cluster 
is busy (by asking clients sequentially if they want to accept a job), Models@Home 
works the other way round: Clients ask the server for a job, only reaching the maxi­
mum number of requests (and thus network load) when the cluster is not used at all.
Server
The server is the link between supervisors and working clients. It manages the job 
queue "cluster.job" and distributes jobs according to their priority. It also handles the 
transfer of job data files from a job-specific directory on the supervisor (via NFS) to 
the working directory on the working client (via TCP/IP). Job results travel back in 
the reversed direction.
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The latest file updates are stored in subdirectory /updates and transmitted to work­
ing clients to replace outdated versions. (In principle any file on the working client can 
belong to this update group, including the Models@Home software and the actual ap­
plications).
The server also collects "still alive messages" from working clients. If a client 
does not send such a message for a given time period, it is assumed to have "disap­
peared without notice" (e.g. a power failure) and the job is retransmitted to another 
client.
Implementation
Models@Home is based on a straightforward client-server architecture using the 
TCP/IP protocol as shown in figure 1. Every client has the Models@Home software 
and all applications that are too large for repeated transmission installed locally (which 
is most easily done by remote administration). The main component of Mod- 
els@Home is a screensaver that becomes active when the client is not used for a cer­
tain time period. Beside displaying some graphical animations, the program contacts 
the central server and requests a new job. Jobs can be added via a Python or C inter­
face. The screensaver detects when a program has finished, returns the specified result 
files and requests a new job. As all this is done by the Models@Home software, it is 
possible to run any program in parallel without modifications to the source code, as 
long as user input is not needed.
The above procedure applies to ideal conditions only. A number of additional fea­
tures had to be implemented to cope with problems encountered in practice:
•  H ard resets and power failures: Computers occasionally stop working, making 
it impossible to notify the server about the job interruption. Clients therefore send a 
"still alive message" in fixed time intervals. Especially short intervals require a per­
manent inter- or intranet connection and exclude any dial-up clients.
•  Program development and bugs: If the program is under development, it is of 
course not reasonable to continuously reinstall it on every client. The Models@Home 
communication protocol therefore includes the time-stamps of selected files including 
executables. These are automatically updated if newer versions are available on the 
server.
•  Security issues: In the majority of cases, Models@Home will be used in the 
intranet only (normally protected by a firewall). Either because this provides already 
enough computer power, or because the programs are not freely distributable, or be­
cause of the large amount of work required to support users outside the department. If 
the "world wild web" is targeted, the update feature mentioned above must be deacti­
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vated, and it is up to the developer to ensure that the executed programs cannot do any 
damage (e.g. a simple SAVE command in a program script could already overwrite 
system files in a Windows environment).
Discussion
The Models@Home environment has been installed and tested on 30 mixed 
Linux / Windows PCs at the CMBI. The following paragraphs describe some of the 
applications and concentrate on the aspects related to parallel execution, the very de­
tails will be described elsewhere.
Molecular Dynamics Docking
A protocol was developed where docking is performed with YASARA during a 
molecular dynamics simulation (see Di Nola et al.2 for an early description of a com­
parable method), which inherently considers both ligand and protein flexibility (Krie­
ger et al., submitted 2001). The ligand is shot towards the protein, allowing side chain 
reorientations during complex formation, followed by a short MD simulation, an ener­
gy minimization (simulated annealing) and the evaluation of the final energy.
To sample conformational space reasonably well, thousands of molecular dynam­
ics simulations with different initial orientations of ligand and protein are required. As 
these are completely independent, the supervisor could spawn all docking jobs at once, 
making molecular dynamics docking an ideally "coarse-grained" application for dis­
tributed computing.
Force Field Parameterization
Selecting force field parameters that optimally fit a given force field equation is a 
lengthy procedure, usually requiring extensive validation studies. In addition it is very 
difficult to obtain an internally consistent parameter set. We therefore let a force field 
"parameterize itself" while energy minimizing protein structures3. This was done with 
Monte Carlo moves in parameter space, that were accepted if the resulting force field 
did less damage to high resolution X-ray structures and at the same time improved 
models built by WHAT IF4.
Each parameter optimization cycle required an energy minimization of 50 protein 
structures. The supervisor therefore spawned 50 jobs. Each job included the PDB file 
of the structure, as well as a YASARA script to do the energy minimization and to 
finally calculate the RMSD from the initial structure. Only this RMSD value was sent 
back as a result. The 50 RMSDs were averaged and used as a progress indicator.
For this application of Models@Home, the rate limiting step was the time it took 
to minimize the largest protein in the set. All RMSDs had to be known before the 
quality of the current force field could be estimated and new jobs could be spawned.
46
More computers would thus not have improved the performance. This is an example 
of a "medium-grained" application.
Database Maintenance
The CMBI hosts a large number of databases, many of which are not mirrored but 
generated in-house. Especially those related to protein structure are often time con­
suming to maintain, like the PDBREPORT database, that lists anomalies in protein 
structures5 (www.cmbi.kun.nl/gv/pdbreport). It contains one entry for every PDB file, 
and is mainly used by modelers to find optimally suited templates.
To keep this database up to date, the supervisor compares it with the PDB once a 
week, deletes obsolete PDB reports and spawns jobs to create new ones. All these jobs 
are independent and parallelize perfectly.
Conclusion
Models@Home provides a flexible environment for parallel execution of different 
applications without the need to modify any of these programs. It is therefore well 
suited for bioinformatics, where both the turn-over of different software packages and 
the requirement for computer power are huge.
Models@Home can be reconfigured for use with different programs without mak­
ing changes to the source code. It is freely available and can be downloaded from 
www.yasara.org/models.
Acknowledgements: We would like to thank all researchers at the CMBI for participating in the 
Models@Home screensaver project.
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When building a  model by homology, a  lot of 
supplementary information about the available 
templates is required. Which parts of the tem­
plate structures a re  well resolved? W here are  
potential errors that will be p ropagated  to the 
model? For structure-based alignment correc­
tion, one needs to know where the secondary 
structure elements a re  located, which residues 
a re  buried, which a re  well conserved and which 
a re  part of structurally divergent regions. All 
these questions a re  answered by the 
PDBFinder2 d a tab ase  described in the next 
chapter.
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PDBFinder II - a database for protein 
structure analysis and prediction
Elmar Krieger, Rob W .W . Hooft, Sander B. Nabuurs and G ert Vriend 
Abstract
The PDBFinder II database provides uniform access to data typically required by 
applications in the fields of protein structure analysis and prediction. These include the 
sequences of experimentally determined structures, chain breaks, assigned secondary 
structure (DSSP), residue variability and entropy, hot-spots for insertions and dele­
tions (HSSP), accessibilities, crystal contacts, B-factors, quality indicators, as well as 
general information parsed from PDB files: experimental methods, resolution, R- 
factor, authors, compounds, chains, hetgroups and many more. The quality indicators 
consist of normality Z-scores describing bonds, angles, torsions, planarity, chirality, 
packing, and inside/outside distribution. Unusual backbone conformations, unsatisfied 
hydrogen bond donors/acceptors, and flips of Asn, Gln and His side-chains are also 
reported.
The database is updated weekly and is available as a flat, human readable text file 
via anonymous FTP from ftp.cmbi.kun.nl/pub/molbio/data/pdbfinder2/ or via SRS at 
www.cmbi.kun.nl/gv/pdbfinder2. A Python plugin for the molecular modeling pro­
gram YASARA allows to load PDB structures and visualize the data by coloring resi­
dues accordingly (www.yasara.org/plugins). A separate Python module to directly ac­
cess the PDBFinder II is also available.
Introduction
While the Protein Data Bank provides the central resource for protein structures, a 
lot of additional information can be found in accessory databases spread all over the 
world. At the CMBI, we maintain the DSSP1 (assigned secondary structure, residue 
accessibilities, hydrogen bonds), HSSP2 (alignments of the PDB sequence against 
Swissprot and TrEMBL), PDBFinder3 (all important information from PDB files, in­
cluding the sequences) and PDBReport4 databases (a detailed structural analysis with a 
focus on potential problems). Researchers in structural bioinformatics often need 
quick, automated access to all these data. So far, this either required separate 
downloads and parsers for each file format, or was simply impossible, e.g. the 
PDBReports are only available in human-, but not computer-readable form 
(www.cmbi.kun.nl/gv/pdbreport/).
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The PDBFinder II database offers quick access to all these and additional data in a 
format that is easily readable for humans as well as computer programs. Applications 
dealing with structure prediction can quickly determine which residues have experi­
mental coordinates, they can correct initial sequence-based alignments by considering 
secondary structure elements, conserved and buried residues, as well as regions with a 
high probability of insertions and deletions. The per-residue quality indicators allow to 
identify the less reliable parts of a structure and build hybrid models consisting of ex­
perimentally well determined fragments in multiple templates. Researchers developing 
new modeling methods can use the PDBFinder II to generate reliable test-sets, that 
exclude residues involved in crystal contacts or problematic structures altogether.
Results
The PDBFinder II file format
The PDBFinder II entry for crambin (PDB ID 1CRN) is shown in Figure 1. In addition 
to information parsed from the PDB header, which is taken from the PDBFinder data- 
base3, the following fields have been added at the chain-level:
•  Sequence: the sequence of all residues with experimentally determined coordi­
nates. Contrary to the original PDBFinder, the sequence contains chain break markers 
‘-‘. This allows to easily align it with the complete sequence deposited in Swissprot or 
given in the SEQRES field of the PDB file.
•  DSSP: the secondary structure assigned by DSSP1, with 'C' indicating 'coil' to fa­
cilitate parsing.
•  Cryst-cont: residues involved in crystal contacts are flagged with a ‘+’ sign.
•  In the remaining fields, numbers or Z-scores are mapped to the range [0..9]. The 
formulas used are described in the header of the PDBFinder II file.
•  Nalign: the number of aligned sequences at this position in the HSSP-file.
•  Nindel: the sum of insertions and deletions.
•  Entropy: and Cons-weight: the sequence entropy and conservation weights as de­
fined in 2.
•  Access: residue accessibilities, ‘0’ is completely buried and ‘9’ is maximally ex­
posed.
•  Quality: overall estimator for the chain quality, obtained by averaging the 
‘Phi/Psi’, ‘Backbone’ and ‘Packing 1’ fields described below (which are among the 
most reliable quality indicators). High resolution X-ray structures reach values around
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0.75, while NMR structures determined from only a few experimental restraints can be 
found around 0.3.
For the following quality-related fields, the mapping is chosen such that ‘9’ corre­
sponds to ‘perfect’ and ‘0’ to ‘requires attention’. Exceptions are the fields ‘Torsions’, 
‘Phi/Psi’, ‘Chi-1/2’, ‘Packing 1’ and ’Packing 2’, where ‘5’ indicates about the aver­
age of high resolution X-ray structures, ‘9’ corresponds to ‘suspiciously good’ and ‘0’ 
to ‘treat with caution’, according to the WHAT_CHECK output4.
•  Present: 9 minus the number of missing atoms per residue.
•  B-Factors: average crystallographic B-factor per residue.
•  Bonds and Angles: absolute Z-score of the largest bond or angle deviation per 
residue according to the Engh&Huber parameters5.
•  Torsions: Average Z-score of the torsion angles per residue. This one and the fol­
lowing Z-scores including ‘in/out’ are calculated from the distributions found in the 
internal WHAT IF database of high resolution X-ray structures6.
•  Phi/Psi: Ramachandran Z-score per residue. No value can be determined for the 
N- and C-terminal residues, which is indicated by a question mark ‘?’.
•  Planarity: Z-score of the side-chain planarity. Residues without a planar side- 
chain always score ‘9’.
•  Chirality: Average absolute Z-score of all ‘improper dihedrals’ per residue, de­
fined by one central and three bound heavy atoms, excluding planar groups. Gly al­
ways scores ‘9’.
•  Backbone: Number of similar backbone conformations found in the database, de­
termined by superimposing stretches of five residues. No score can be obtained for the 
N- and C-terminal two residues. If less than 10 hits are found, there are not sufficient 
data to perform the following two checks for peptide plane flips and rotamers (indi­
cated by question marks).
•  Peptide-Pl: RMS distance of the backbone oxygen from the oxygen in similar 
backbone conformations found in the database. Low scores indicate that the peptide­
plane may have been flipped.
•  Rotamer: Probability that the side-chain rotamer (chi-1 only) is correct. Gly, Ala 
and Pro always score ‘9’.
•  Chi-1/Chi-2: Z-score for the side-chain chi-1/chi-2 combination.
•  Packing 1: Three-dimensional packing quality Z-score7.
51
ID
Header
Date
Compound
Source
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Author
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Chain
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Planarity
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46
46
22
3
4 
4
46
6
TTCCPSIVARSNFNVCRLPGTPEAICATYTGCIIIPGATCPGDYAN 
CEECSSHHHHHHHHHHHTTTCCHHHHHHHHSCEECSSSCCCGGGCC 
2777777777777777777777777777777777777777777777 
0000000000000000000010100000000000000200000000 
01003435212 4114 0034 0434 44 005 63302133454 0153243 
9798435378 62983997394 4344 982155 95765523973574 4 
4200347 6225 425 62477 62 6355 0276241342 957834762 63 
++++ + + +++++++ + + +  + + +  +++
0.6450
9999999999999999999999999999999999999999999999 
9999999999999999999999999999999999999999999999 
9899897999989989999998698897979999892979999999 
2699996999908089899798899898679996696737996929 
?64644647678687546352666375655764644423755543? 
?45545655666665434455646453453654644433754335? 
9999999999999999999999999999999999999999999999 
0899999999999999989999999999999999999999998979 
??99999999999999991979999999999699998 6999999?? 
??9999999999999999?9?9999999999?8 999??999999?? 
??559959954767969699?9699899799?9849999799899? 
4444555454574644455545653454545546555544554455 
9999909099999999904990999999099999999999999999 
6489397666677654013238656653014663314314631213 
9466653456674655444547434744336843142536653532 
9999999999999999999999999999999999999999999999 
9999979799999999999999999999999999999999999979 
9999999999999999999999999999999999999999999999
32.
0.
0.
0.
0.
0.
1.
0.
0.
0.
0.
0.
1.
0.
0.
0.
0.
0.
0.
0.
0.
0.
0.
1.
Figure 1: PDBFinder II entry of 1CRN
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•  Packing 2: Second packing quality Z-score.
•  In/Out: Absolute Z-score for the residue accessibility.
•  Bumps: Sum of bumps (i.e. difference between the van der Waals- and the actual 
distance) per residue.
•  H-Bonds: 9 minus the number of unsatisfied hydrogen bonds. Additional penal­
ties: 1 is subtracted for buried unsatisfied backbone nitrogens, 4 for unsatisfied side- 
chain hydrogen bonds.
•  Flips: Asparagine, glutamine and histidine side-chains that need to be flipped in 
the optimum hydrogen bonding network8 are scored with ‘0’, all other residues with
‘9’.
Unless indicated otherwise, numbers at the right border (separated with a pipe 
symbol ‘|’) are the average over the chain, multiplied with 0.9. This average is calcu­
lated before the individual residue values are saturated to fit into the interval [0..9] and 
can therefore lie outside the corresponding interval [0..1].
Database interfaces
A Python plugin for the molecular modeling program YASARA 
(www.yasara.org/plugins) allows to load PDB structures, automatically retrieve the 
corresponding PDBFinder II entry via HTTP and map the information onto the struc­
ture. An example is shown in figure 2, where trypsin has been colored according to the 
HSSP conservation weights. A separate Python module to access the PDBFinder II 
directly is available from www.yasara.org/biotools. Both are licensed under the GNU 
GPL.
Figure 2: Crystal 
structure of trypsin 
from Atlantic
salmon9, colored by 
HSSP conservation 
weights. Blue corre­
sponds to ‘not con­
served’ and yellow 
to ‘completely con­
served’. The Ser- 
His-Asp catalytic 
triad is indicated.
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With all the required tools in place, it is time to 
start the actual work. As mentioned in the sum­
mary, predictions in structural bio-informatics 
must become much more accurate before they 
can compete with true experiments in fields like 
drug design or structure determination. As p re­
dictions mostly depend on the underlying en­
ergy- or scoring functions, the following chapter 
is devoted to finding new approaches that in­
crease the accuracy of today’s energy func­
tions.
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Proteins a re  huge molecules, consisting of thou­
sands of atoms. That’s why it is not feasible to 
apply  the well developed tools of quantum 
chemistry, which can cope with only a  few 
dozen atoms a t most. Instead we need simpli­
fied empirical energy functions, which a re  d e ­
signed to capture the most important features 
but leave out the fuzzy details. One such en­
ergy function is described in the next chapter: 
the NOVA force field. With NOVA, it is possi­
ble to energy minimize homology models and 
actually improve them, which can be harder 
than many people believe.
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Abstract
One of the conclusions drawn at the CASP4 meeting in Asilomar was that apply­
ing various force fields during refinement of template-based models tends to move 
predictions in the wrong direction - away from the experimentally determined coordi­
nates. We have derived an all-atom force field aimed at protein and nucleotide optimi­
zation in vacuo - NOVA - which has been specifically designed to avoid this problem. 
NOVA resembles common molecular dynamics force fields, but has been automati­
cally parameterized with two major goals: 1) Not to make high resolution X-ray struc­
tures worse and 2) to improve homology models built by WHAT IF. Force field pa­
rameters were not required to be physically correct, instead they were optimized with 
random Monte Carlo moves in force field parameter space, each one evaluated by 
simulated annealing runs of a 50 protein optimization set. Errors inherent to the ap­
proximate force field equation could thus be canceled by errors in force field parame­
ters. When compared to the optimization set, the force field did equally well on an 
independent validation set and is shown to move in silico models closer to reality. It 
can be applied to modeling applications as well as X-ray and NMR structure refine­
ment. A new method to assign force field parameters based on molecular trees is also 
presented. A NOVA server is freely accessible at www.yasara.org/servers
Introduction
The search for Nature's folding function has been a tempting scientific adventure 
ever since Linus Pauling predicted the a  helix back in 19511. As an accurate quantum 
chemical calculation of the true energy function is still hardly feasible for macromole­
cules, one works with approximations, like the AMBER2, CHARMm3 or GROMOS4 
molecular dynamics force fields.
When developing a new force field, the first step is to set up a general equation 
that matches the various forces present in the studied system. Then one defines rules 
to derive force field parameters from quantum chemical calculations or experimental
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measurements on (usually) small molecules. Here we took a different approach and 
just defined three goals:
(1) For every global (or lowest accessible local) minimum of the true conformational 
free energy, a minimum of NOVA should lie close by.
(2) The regions around the minima of NOVA need to be as smooth as possible and 
thereby facilitate energy minimization algorithms.
(3) NOVA should be a function of solute atom coordinates only, the solvent must thus 
be implicitly included. (See Roux & Simonson5 for a recent review of implicit solvent 
models).
The force field was allowed to "parameterize itself" while trying to optimally ful­
fill these goals. This was achieved by randomly changing force field parameters and 
evaluating the "fitness" of the resulting force field with a protocol step by step match­
ing the three goals defined above:
(1) Energy minimization of high resolution X-ray structures: The smaller the RMSD 
from the initial structure, the closer are the NOVA minima to reality.
(2) Energy minimization of homology models built for high resolution X-ray struc­
tures: The smaller the RMSD to the experimental structure, the better is the energy 
landscape suited for getting there. (Other methods for smoothing and reducing the 
height of energy barriers include umbrella sampling and soft-core potentials6-8).
(3) All energy minimizations are done as in vacuo.
To make such a global search in force field parameter space computationally fea­
sible, the number of optimized parameters had to be kept small. Precisely known pa­
rameters (i.e. equilibrium bond lengths and angles) were not optimized. Well known 
parameters (i.e. bond stretching and angle bending force constants) came from the 
AMBER force field and were rescaled together using two scaling factors: one for the 
bonds, and one for the angles. All other parameters (e.g. Van der Waals interactions 
and off-center point charges) were optimized independently. To further reduce compu­
tational requirements, the energy minimization algorithm searched for NOVA's closest 
minimum. It can therefore only be guaranteed that NOVA has minima close to real 
protein structures, but not that these minima are also global ones.
Algorithms that search for global minima with big steps in conformational space 
(e.g. ab initio fold prediction9) can be applied safely if the search is restricted to a spe­
cific region with additional data (like NMR NOESY restraints). NOVA is useful for 
applications that require a search for a local minimum near by, like refinement of ex­
perimental low resolution structures, models built by homology or docked complexes. 
The force field is shown to significantly reduce the Ca RMSD between experimental 
structures and theoretical models during an energy minimization.
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Methods
The NOVA force field (protein + nucleotide optimization in vacuo) has been im­
plemented as part of the newly developed interactive real-time molecular dynamics 
program YASARA ("Yet Another Scientific Artificial Reality Application", 
www.yasara.org). It looks like common molecular dynamics force fields, with the to­
tal energy being expressed as a sum of individual contributions: Bonds, angles, planar­
ity, Van der Waals, and electrostatic terms. Most negative point charges are placed 
outside the nuclei (off-center charges), Van der Waals interactions are modeled by 
Born-Mayer Exp6 instead of the familiar Lennard Jones 12-6 potentials. Planarity is 
treated by least-squares plane fitting instead of improper torsions.
Molecular trees define the chemical environment
One of the aims during the development of NOVA was the possibility to extend 
the force field to ligands without the need for manual intervention. This was achieved 
by using molecular trees (Figure 1) instead of predefined atom types to assign the 
force field parameters. Normally a topology file lists all atoms by name (e.g. N, H, 
CA, 1HA, 2HA, C, and O for Glycine) and assigns at least an atom type and often also 
a point charge. Bond lengths, angles etc. are specified for all combinations of atom 
types.
In contrast, YASARA builds a molecular tree to define the chemical environment 
of every atom, and then chooses force field parameters based on the closest reference
tree found in the 
NOVA definition file 
(electronic supple­
ment). Starting from 
every atom in the 
molecule (the root) the 
program follows the 
various branches (the 
chemical bonds) of the 
molecule - up to a cer­
tain recursion depth 
(usually 3).
An example is the 
molecular tree built 
from the CP atom of 
phenylalanine (Figure 
1). Bond types (single,
Figure 1. A phenylalanine residue (left). The CP carbon atom 
marked with an arrow serves as the root for creating the 
molecular tree shown on the right. All atoms in the gray area 
are within recursion depth 3 of the root and thus part of the 
tree. Beside the topology, the tree stores data about the bond 
types as well: single, double and resonance bonds are shown 
(the weaker resonance effects of the peptide bond are not 
considered). From top to bottom, the parts of the tree are called 
"depth 3'7'depth 2”,”depth 1” and "root". A comparable tree is 
generated for every atom in the simulated system, force field 
parameters are then assigned based on the most similar tree in 
the force field definition file.
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double, triple and resonance) are an integral part of the tree. These types are taken 
from a connectivity table that contains atom names and bonds for every residue or 
ligand. These tables can be generated automatically by analyzing heavy atom coordi­
nates, predicting their hybridization state and adding hydrogens where needed. This is 
for example done by the Dundee PRODRG Server10 (http://davapc1.bioch.dundee. 
ac.uk/programs/prodrg/prodrg.html). Each molecular tree can also be written as a sin­
gle string, e.g. for the CP of Phe:
CH2(-C(-NH-C)-C(=O)-N)-C(^CH^C) ^CH^C
Comparable approaches have been suggested before (e.g. by Levitt11 or Wein- 
inger12). Here we extend this approach to assign a complete set of force field parame­
ters.
Building reference trees
The NOVA definition file (available from www.yasara.org/nova) does not explic­
itly specify equilibrium bond lengths and angles. These are extracted from the 25 
highest resolution X-ray structures in the PDB, with less than 30% sequence identity, 
obtained from the PDB-SELECT algorithm13 (a list with PDBID codes of all proteins 
used in this work is also available from the above address). Missing hydrogen atoms 
were added with the WHAT IF hydrogen bonding network optimizer14, and then re­
laxed to the closest energy minimum with the AMBER force field1 (parm94), while all 
heavy atoms were kept fixed. For each atom in these proteins a molecular tree was 
built. The distances between the root and depth 1 atoms (the bond lengths in Figure 1) 
and between any two depth 1 atoms (the bond "angles") are stored within the tree. If 
two atoms share the same local covalent structure, their molecular trees are identical. 
Bond lengths (and also angles) were therefore averaged over identical trees. This way 
the program obtained a set of partly residue-dependent bond lengths and angles, that 
can capture features which are missed when using residue-independent parameters.
Bonds
Chemical bond stretching is described by a harmonic potential. Bond lengths (Rj0 
in Figure 2) are taken from the reference trees. The initial bond stretching force con­
stants came from the AMBER Parm94 set. During force field parameter optimization, 
one common scaling factor (parameter 1 in Table I) was assigned to the force con­
stants. The final optimized values (kj in Figure 2) are listed in the NOVA definition 
file. To associate a force constant to a type of bond, slightly modified molecular trees 
are used (as in the case of VdW parameters): Instead of choosing any of the two 
bonded atoms, the bond itself becomes the root of the tree. There are thus always two 
atoms with depth 1 and the bond type is the same for both of them.
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Figure 2. The YASARA NOVA force field. Atom distances are named R, equilibrium values 
Ro. Vectors are shown in bold print. The energy contribution of atom a (Ea) is the sum over all 
chemical bonds (to atom j, with bond stretching force constant kj, j<a), plus a planarity term 
(0.5*lp*Rp2), plus the sum over all non-bonded Van der Waals interactions (with atom i, using 
EXP6-potential parameters Ai? Bi and Ci? i<a), plus the electrostatic Coulomb-interactions be­
tween all m point charges on atom a and n point charges on atom k (k<a). More details are 
given in the methods section and the electronic supplement.
Angles
Bond angles are treated like true bonds between 1-3 bonded atoms (Urey-Bradley 
method). Equilibrium distances (Rj0 in Figure 2) are taken from the reference trees, the 
initial angle bending force constants were converted to the required distance depend­
ent form from the AMBER Parm94 set. Again one common scaling factor (parameter 
2 in Table I) was assigned to all the angle bending force constants. The final optimized 
values (kj in Figure 2) can be found in the NOVA definition file.
We chose the Urey-Bradley approach for two reasons:
(1) Numerical stability: In many typical NOVA applications, very high temperatures 
(5000 K) temporarily cause bond angles to approach 180°. This creates problems with 
angle dependent formulations which contain a singularity at 180° and assign very 
large forces close to this angle, that can trap part of the molecule in an unrealistic local 
minimum (mainly if it belongs to a planar group).
(2) At least qualitatively, the Urey-Bradley method implicitly contains a bond/angle 
cross-term which is normally missing. (A change in bond lengths influences the bond 
angles and vice versa.)
Dihedrals
Accurate potentials are more difficult to obtain for torsions. We therefore decided 
to optimize all parameters. To achieve this goal without making the set of optimization 
parameters too large, we reduced the torsion forces to the repulsion between 1-4 
bonded atoms. 1-4 interactions are thus treated exactly like non-bonded interactions. 
However, because Lennard-Jones 12-6 potentials do not model the torsion energy 
properly, we chose the more flexible Born-Mayer Exp6 potentials15, combined with 
"distant geometry links".
A difficulty with this approach is the hydrogen bonding problem: The electro­
static attraction between the point charges on polar protons and H-bond acceptors is
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normally not large enough to compensate for the Van der Waals repulsion. This re­
quires a large reduction of the Van der Waals radii of polar protons, which in turn 
leads to unrealistic torsion energy profiles that must be corrected with additional 
terms. By using negative off-center point charges, we increased the electrostatic attrac­
tion between proton and acceptor sufficiently to reproduce the experimental H-bond 
lengths of about 1.9 Á, while still keeping realistic VdW parameters.
Distant Geometry Links
Many planar groups contain charged atoms in close proximity. E.g. the terminal 
hydrogen atoms HH12+HH22 and HH21+HE in Arginine are separated by four bonds, 
but lie very close to each other. The distance is about 2.3 Á, leading to repulsive Van 
der Waals forces. The atoms are all positively charged, adding further repulsive forces 
with a non-negligible influence on the molecular geometry. But these forces are al­
ready implicit in the equilibrium bond lengths and angles taken from the high resolu­
tion structures. Distant geometry links (DGLs) define such critical atom pairs and link 
them with a pseudo-bond to exclude them from the calculation of non-bonded interac­
tions.
Planarity
All force field terms considered so far were a function of the distance between 
two atoms. Planarity of atom groups is one of the features that cannot be based on 
atomic distances only, as out-of-plane bending is accompanied by only small changes 
in distances. Here we present a method that differs from the normally used "improper 
dihedrals". It is fast and has some advantageous features when used with the NOVA 
force field. Our approach calculates the optimal plane through all members of a planar 
group. Knowing the normal vector of the plane, a force towards the plane is applied to 
every atom. For a given atom Ai, this force is simply the distance from the plane (Rp in 
Figure 2) times the "plane stretching force constant" lp (parameters 3+4 in Table I): 
Fp= -Rp*lp. A compensating force -Fp/n is applied to all the n atoms bound to Ai. While 
not entirely conserving energy, this approach offers the advantage that the least- 
squares plane fitting has to be done only once per planar group every time step, and 
that the resulting normal vector can be used to apply non-spherical Van der Waals po­
tentials in DNA base pair stacking.
Van der Waals Interactions
The NOVA force field uses Born-Mayer potentials15 to describe interatomic 
forces. This function consists of an attractive R-6 term and a short-range exponential 
repulsion term:
E = A * e"B*R - C / R6 (1)
Our reasons for choosing this function were:
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(1) The Born-Mayer Exp6 function contains three adjustable parameters and thus al­
lows us to shift the root independent of the minimum, whereas the more common 
Lennard Jones 12-6 potential always has its root at 0.89 times the distance of its 
minimum.
(2) As there is no need to minimize numerical noise as in long-time MD simulations, a 
simple look-up table can be used to avoid the very expensive evaluation of the expo­
nential term. This approach is particularly handy because the Exp6 function requires 
special care at short distances: When R approaches zero, the repulsive term reaches A 
(see equation 1) whereas the attractive part tends towards -infinity. The potential thus 
becomes attractive again at close separations, somehow resembling "nuclear fusion". 
We therefore replaced the interval from 0 to the first root of the third derivative with 
an R-12 damping function.
Initial parameters were taken from a table published by Mirsky16, manually ad­
justed by up to 5% so that secondary structure elements did not fall apart and a stable 
starting guess was available, then parameters were optimized for all atom pairs, no 
combining rules were used. To keep the number of parameters below a reasonable 
limit, all interactions involving sulfur were not optimized but taken from AMBER 
Parm94 and transformed to Exp6 format.
The Exp6 parameters make the largest contribution to the optimization set (pa­
rameters 14 to 43, Table I).
Electrostatics
The electrostatic forces are 
added by assigning point 
charges to the atoms. To maxi­
mize the level of consistency 
with the remaining force field, 
all electrostatic parameters were 
optimized. This required a de­
scription of the essential fea­
tures with a minimal set of 9 
parameters (Table I). These in­
cluded the charges and also their 
positions, if placed outside the 
nucleus. Using off-center point 
charges was required mainly for 
hydrogen bonds. As numerical 
long-time stability is not an is-
\
P+ P
C=O
/ <—  
1.23 A
Figure 3. Placing off-center point charges as a lin­
ear combination of atom coordinates. If the distance 
x of the partial charge P- from the O nucleus was 0.8 
A, the weighting factors i, j for coordinates O, C to 
obtain P- would be: P- = O + (0.8 / 1.23) * (O - C), 
P- = (0.8 / 1.23 + 1) * O - (0.8 / 1.23) * C and thus 
i=1.65, j=-0.65. In this case, the position of the point 
charge depends on the length of the C=O bond.
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sue, charges can be assumed mass-less. Forces 
are thus calculated between the charges, but 
they act on the associated nuclei. After each 
change in atom positions, the coordinates of the 
point charges are recalculated based on the fol­
lowing rules:
•  Central charges: these are simply placed at 
the coordinates of the nucleus.
•  Charges with positions that can be obtained 
as a linear combination of atom coordinates: A 
typical example is the lone pair of the carbonyl 
group (Figure 3).
•  Charges with positions that require the cal­
culation of a vector product: The lone pair co­
ordinates of sp3 hybridized atoms (like the 
oxygen in hydroxyl groups or water, Figure 4) 
cannot be determined with a simple linear com­
bination of atom coordinates. The point charges 
are placed in a plane N defined by vectors a and 
c (Figure 4), where c is a x b. a and b are them­
selves linear combinations of atom coordinates.
Initial guess values for the various charges 
were obtained from the experimentally meas­
ured dipole moments of small molecules, the 
ST2 parameters17 were used for hydroxyl groups. Ionic charges were set to 0.3e. Then 
the parameters were optimized (Table I).
Optimization and validation sets
The aim was to create an optimized force field that does not make highest resolu­
tion X-ray structures worse while at the same time improves approximate models dur­
ing an energy minimization procedure. The generation of the required optimization 
and validation sets of proteins (each one consisting of 25 high resolution structures 
and 25 models of high resolution structures) was done automatically based on a list of 
highest quality PDB chains with less than 30% sequence identity, no chain breaks, 
resolutions better than 1.9 A and R-factors below 0.19, generated by the PDB- 
SELECT program13.
a
Figure 4. Placing off -center point 
charges at sp3 hybridized atoms. 
This example shows the application 
of the method to the ST2 water 
model. The required parameters are 
the number of atoms and weighting 
factors needed to calculate the vec­
tors a and b, the number of charges 
placed in the plane defined by a and 
c (c = a x b) and finally for each of 
these charges the plane coordinates 
and size.
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Parameter Parameter description
1 Common scaling factor for all AMBER bond stretching force constants
2 Common scaling factor for all AMBER angle bending force constants
3 Planarity force constant of peptide plane
4 Planarity force constant of all planar sidechains (D,E,F,H,N,Q,R,W,Y)
5 Charge c at H (+c) and N (-c) in peptide bond
6 Charge c at C (+c) and O (-c) in C=O groups
7 Distance from O-nucleus of the negative lone "pair" in C=O groups
8 Charge c at H (+c) and N (-c) in aromatic rings (H,W) and NE/HE of R.
9 Charge c at H (+c) and N(-2c or -3c) at NH2 and NH3 groups (N,Q,K,R,N-term.)
10 Ionic charge (D,E,K,H-protonated,R,N-terminus,C-terminus)
11 Charge c at C (+2c) and O (-c) in deprotonated carboxyl groups (E,D,C-term.)
12 Distance from O-nucleus of the negative lone "pair" in carboxyl groups
13 Charge c at H (+c), O (-c per lone pair) and C (+c) at hydroxyl groups (S, T, Y, D- protonated, E-protonated, C-terminus protonated)
14-16 Born-Mayer parameters of H - H interaction
17-19 Born-Mayer parameters of H - C interaction
20-22 Born-Mayer parameters of H - N interaction
23-25 Born-Mayer parameters of H - O interaction
26-28 Born-Mayer parameters of C - C interaction
29-31 Born-Mayer parameters of C - N interaction
32-34 Born-Mayer parameters of C - O interaction
35-37 Born-Mayer parameters of N - N interaction
38-40 Born-Mayer parameters of N - O interaction
41-43 Born-Mayer parameters of O - O interaction
Table I. The optimization parameters of the NOVA force field. Equilibrium bond lengths and 
angles are taken from high resolution X-ray structures without optimization. Bond stretching 
and angle bending force constants come from the AMBER force field and are rescaled (pa­
rameters 1 and 2 above).
For each of these chains, the script searched for a modeling template in the corre­
sponding FSSP file18. If there existed a template that allowed modeling the chain 
without insertions or deletions, and had less than 93% sequence identity, the model 
was built with WHAT IF19 and added to the group of models (M), otherwise the chain 
became part of the structures group (S). 93% was the lowest value that allowed to 
reach the required number of 50 structure-model pairs. The first 25 odd entries of M 
and S were taken as optimization set, the even entries as validation set. The 25 entries 
in group S of the optimization set were also used to generate the reference trees.
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The practical limit of fold prediction
Comparisons of experimental crystal structures indicate limits on the accuracy 
that can be reached in structure determination experiments. They also reveal practical 
limits of fold prediction.
Using the PDBFINDER database20, we identified chains with identical sequences, 
that have been solved by different authors and refinement programs at resolutions bet­
ter than 1.9 A. For these structure pairs, Ca, backbone and heavy-atom RMSDs were 
calculated, defining the experimental uncertainty of coordinates obtained at high reso­
lution (top and bottom outliers were removed). We used these values (0.48 A for Ca, 
0.95 A for all heavy-atoms) to define how much the force field may modify a structure 
during an energy minimization before we know that it got worse.
Force field optimization methods
The NOVA force field described in this study has been optimized by Monte Carlo 
moves in parameter space. After every step, the quality of the force field was evalu­
ated by running "simulated annealing" molecular dynamics simulations for the 50 
structures in the optimization set with YASARA and the following protocol: The non­
bonded force cutoff was set to 10.5 A. 100 steps of steepest descent minimization with 
a maximum step size of 0.05 A removed any sources of conformational stress that 
might lead to a collapse of the following simulation. Velocity vectors were initialized 
to average values found at 298 K4 followed by 3800 integration steps of the equations 
of motion with the leapfrog algorithm, using a time step of 2 fs for electrostatic plus 
Van der Waals interactions and 1 fs for all harmonic forces including planarity.
The random initial velocities were required to avoid optimization towards force 
field vectors with zero length, that are guaranteed not to introduce errors. The distor­
tion at the beginning made sure that a realistic parameter set with the ability to "pull 
the structure back to where it belongs" was obtained. Every 20 fs, all velocity vectors 
were scaled by 0.9, the protein was thus slowly frozen. After 3.8ps, the time steps 
were reduced by 50% to 1 fs and 0.5 fs, respectively, for another 200 cycles. Finally 
the Ca, backbone and heavy-atom RMSDs were calculated (with respect to the start­
ing structure (group S) or the modeling target (group M)). The heavy atom RMSDs of 
all 50 proteins were averaged and used as a progress indicator. A move in parameter 
space was accepted with a probability of
p = exp ( - (RMSDnow - RMSDbest) / 0.00045)
The value of 0.00045 for kT was empirically chosen so that progress was steady 
but local minima could still be escaped. A total of 43 force field parameters were sub­
jected to this minimization procedure (Table I). Each Monte Carlo move was done by 
picking one parameter randomly and then either increasing or decreasing it 1 to 10
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times the minimal step size. The minimal step size was predefined for every parame­
ter, and equivalent to the final precision required (0.002e for charges, 2% for scaling 
factors, planarity force constants and VdW contact energies, 0.01 A for VdW radii and 
VdW potential roots).
Force field evaluation methods
After the optimization converged, the force field was evaluated with an extensive 
minimization: 250 steps of steepest descent and long 40 ps simulated annealing runs 
without initial velocities. Time steps were 1 and 0.5 fs for the first 4 ps and 2 and 1 fs 
for the remaining 36 ps. Force field energies were calculated without a cutoff distance 
every 200 fs. If the energy did not drop during five of these measurements (1000 inte­
gration steps), the energy minimum was reached and the procedure stopped (corre­
sponding to horizontal lines in Figure 8). This avoided the problem that simulated an­
nealing does not stop at the true energy minimum if a cutoff distance is used (it pro­
ceeds further to the minimum of the truncated energy function, leading to an increase 
in true energy).
Computational requirements
The force field optimization required about 20000 hours of CPU time. The calcu­
lations were done on 26 PCs at the CMBI, using Models@Home, a freely available 
screen-saver that turns a network of normal, non-dedicated PCs into a distributed 
computing cluster (www.yasara.org/models). Two months of computer time could be 
saved by implementing the NOVA force field in Assembly language.
Results
Force field optimization
Our goal was to parameterize a force field for energy minimization of proteins, 
that 1) does not "mess up" high resolution X-ray structures and 2) moves predicted 
models closer to reality. Most parameters were not chosen based on measured or cal­
culated physico-chemical properties, but instead freely optimized with Monte Carlo 
moves in force field parameter space. Each move was evaluated with energy minimi­
zations (by simulated annealing) of a 50 protein optimization set: 25 high resolution 
X-ray structures and 25 homology models built by WHAT IF19.
The parameter optimization progress is shown in Figure 5 for the 25 high resolu­
tion structures. Three distinct regions are visible: During the first 100 optimization 
steps, the force field improved rapidly. The damage done to the Ca coordinates during 
the 4 ps minimization decreased by 0.15 A. At step 100, the "low hanging fruits" were 
gone, the first local minimum was reached. From here on, a Monte Carlo algorithm 
that can escape local minima was obligatory. Nevertheless, there was slow but steady
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progress till step 450. From step 
450 on, improvement was 
minimal but still measurable.
Around step 600, the optimizer 
finally passed the experimental 
uncertainty barrier of 0.48 A 
(Figure 5) for Ca atoms: Below 
0.48 A RMSD, it is impossible 
to decide whether the structure 
got worse during the minimiza­
tion or not. The heavy atom 
RMSD barrier lies however 
much higher, at about 0.95 A.
This can be attributed to the in­
fluence of crystal contacts on 
surface rotamers, which can not 
be exactly determined experi­
mentally and thus increase the 
RMSD. After 1000 steps (and 
thus 50000 simulated annealing 
runs) the procedure converged.
Force field evaluation
The above results apply to 
the optimization set only, and 
were obtained for short 4 ps 
simulating annealing runs. (By
making the minimization time short enough, one can stay arbitrarily close to the initial 
structures.) The truly important question is: How far are the NOVA minima away 
from reality? This can only be answered with an extensive simulated annealing run 
that proceeds till the energy converges. The result is shown in Figure 6 for an inde­
pendent validation set of another 25 structures.
Before parameter optimization, the force field undoubtedly made the 25 high 
resolution structures worse. The energy minima lay 0.15 A (heavy atom RMSD) and 
0.39 A (Ca RMSD) above their experimental boundaries (Figure 6). During optimiza­
tion, the minima moved closer to reality by 0.30 A (heavy atoms) and 0.27 A (Ca). 
The Ca RMSD thus came close to the boundary, while the heavy atom RMSD crossed
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Figure 5. Force field optimization progress shown 
for the 25 high resolution structures in the optimiza­
tion set. The average heavy atom (upper curve, 
gray) and Ca RMSDs (lower curve, black) after 
~4 ps simulated annealing runs are drawn as a func­
tion of the optimization step. The two horizontal 
lines mark the border of experimental uncertainty 
(i.e. 0.95 A for the heavy atom- (top) and 0.48 A for 
the Ca-RMSDs (bottom) observed if the same 
structure is solved at high resolution by different 
authors and refinement programs). Anything above 
these lines surely got worse during the minimiza­
tion. To make the optimization procedure computa­
tionally feasible, every simulated annealing run 
lasted only 4 picoseconds (and did not always reach 
the energy minimum). Exhaustive simulated anneal­
ing runs that proceed till the energy minium is 
reached are shown in Figure 6.
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Figure 6. Extensive minimization of the structure 
validation set (25 proteins). The two horizontal lines 
mark the experimental boundaries described in Fig­
ure 5. The average heavy atom (gray curves) and 
Ca RMSDs (black curves) are shown as a function 
of simulated annealing time. Dashed curves were 
obtained with initial force field parameters, solid 
curves with final optimized parameters.
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Figure 7. Force field parameter optimization results 
for optimization sets (OS) and validation sets (VS) 
of 25 structures and 25 models. For each of the four 
groups, the following values are shown: Average 
heavy atom RMSD before and after parameter op­
timization (bright gray and gray bars) and Ca 
RMSD before and after optimization (dark gray and 
black bars). RMSDs are measured after a 40 ps 
simulated annealing run. The two horizontal lines 
mark the experimental boundaries described in Fig­
ure 5. Time dependent results for the structure vali­
dation set (group 3) are shown in Figure 8.
it and converged 0.15 A below. 
Figure 7 shows the results for all 
100 proteins involved.
Model improvements
Not to mess up high resolu­
tion structures can be regarded as 
a basic requirement. But to be of 
practical use, the force field must 
also be able to move models to­
wards reality. We concentrate on 
the evaluation of Ca RMSDs to 
indicate that a true improvement 
in backbone geometry and not 
just rotamer prediction accuracy 
was obtained. It is important to 
note that WHAT IF was only 
used to mutate the side chains, 
the backbones of the templates 
were simply copied to the mod­
els.
Figure 8 shows the energy 
minimization results for the 25 
models in the validation set. 
There are two different regions to 
deal with: If the model is already 
very close to the true structure 
(Ca RMSD < 0.9 A) it gets 
slightly worse during the mini­
mization, otherwise it is signifi­
cantly improved (up to 0.25 A as 
in the case of the 1CYO model 
(top curve in Figure 8)). This 
result was to be expected: the 
closer one gets to the true struc­
ture, the more accuracy in the 
force field is required to improve 
the model.
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The solution is obvious: 
Not to energy minimize if the 
model is closer than 0.9 Â to its 
high resolution X-ray structure. 
Because this RMSD is of course 
not known at the time of model­
ing, the decision must be based 
on different grounds. We de­
rived the following empirical 
rule from the optimization set:
Only minimize a model i f  
template resolution (Â) divided 
by sequence identity (%) is lar­
ger than 0.04.
We applied this rule to the 
validation set and obtained the 
results shown in Figure 9. Ini­
tially, minimizing the models 
clearly made them worse (Ca 
RMSD increased from 1.36 to 
1.54 Â). During the parameter 
optimization, the model RMSD 
dropped from 1.54 Â to 1.40 Â,
0.04 Â above the initial RMSD 
without minimization. By en­
ergy minimizing only the mod­
els that match the selection rule, 
we found a true improvement: 
The backbone moved on aver­
age 0.111 Â (Ca) closer to real­
ity (bottom curve in Figure 9).
To investigate the perform­
ance of NOVA relative to other 
force fields, we ran exactly the 
same energy minimization pro­
tocol also with the AMBER 
force field. While NOVA with
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Figure 9. Average changes of Ca RMSDs during 
an extensive minimization of the model validation 
set. Results for the AMBER and NOVA force fields 
are shown. The minimization protocol was identical 
in both cases, only the central force field equation 
was changed. Gray lines correspond to the complete 
set (25 models), black lines indicate the subset of 
those models, where template resolution divided by 
percentage sequence identity was >0.04 (14 mod­
els). As this subset has a different average RMSD, 
only changes in RMSD are displayed. The perform­
ance of NOVA before optimization is also shown 
(dashed line).
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Figure 8. Extensive minimization of the model 
validation set (25 proteins) with the optimized force 
field parameters. 11 non-overlapping of 25 trajecto­
ries are shown.
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the initial parameters did clearly worse, it is apparent from Figure 9 that the optimiza­
tion procedure allowed to turn around and go into the right direction.
Force field energy
Ideally, one would like the RMSD to decrease further than the 0.111 A obtained 
above, all the way down to the experimental limit of 0.48 A. It is obvious from Figure 
8, that the proteins "get stuck" too early. Two reasons are possible: 1) The NOVA en­
ergy function is not accurate enough, or 2) the simulated annealing procedure is not 
adequate to find the way down.
Low temperature simulated 
annealing allows backbone shifts 
and reorientations of flexible sur­
face rotamers, but certainly not a 
complete flip of a buried trypto­
phan. If such a rotamer is initially 
not predicted correctly, the 
minimization can easily get stuck 
in a wrong local minimum. To 
verify this hypothesis and clarify 
the possible involvement of point 
1), we compared the NOVA en­
ergies of the models with those of 
the true structures. The latter 
should of course always be 
lower. Energies were calculated 
after 40 ps simulated annealing 
simulations, models and struc­
tures were subjected to the same 
procedure. The results are shown 
in Figure 10.
In three of 25 cases, the real structure has a higher energy than the model. Struc­
tures 4 and 5 are not a big surprise, as Figure 8 has already shown that the force field 
loses its discriminative power below 0.9 A Ca RMSD. If it were possible to "home in" 
from 2.4 to 0.9 A, this would already be a huge step forward. Model 24 however looks 
disappointing at first sight: It has a lower energy than the X-ray structure and 2.3 A 
Ca RMSD. Closer inspection reveals surprising characteristics: Hirustasin, a serine 
protease inhibitor, does not have an exactly determined native fold. It is a highly flexi­
ble protein21, with a very loose residue packing (the WHAT IF packing quality Z-
Structure and Model Energies
>MP
Figure 10. Comparison of model and structure en­
ergies. The Ca RMSDs between the 25 homology 
models in the validation set and their true structures 
are shown in black (models have been sorted by 
RMSD). The gray curve indicates the differences 
between structure and model energies, while the 
black curve serves as the root: as long as the true 
structure is lower in energy than the homology 
model, the gray curve stays below the black one. 
Every tick on the right axis corresponds to 1kJ/mol 
NOVA energy difference per residue.
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score22 is -5) and almost no secondary structure (of 51 amino acids in 1BX7, 43 are 
neither strand nor helix, according to DSSP23). The only reason why this protein does 
not fall apart are five disulfide bonds. By assigning very similar energies to both con­
formations (the structure 1BX7 and the modeling template bdellastasin 1C9P-B) 
NOVA predicted this high level of flexibility.
Discussion
We developed an all-atom force field that moves models on average 0.111 A (Ca 
RMSD) closer to their true structures, in cases for which template resolution divided 
by percentage sequence identity is larger than 0.04. This result was achieved with an 
optimization in force field parameter space, that allowed to obtain a set of parameters 
that optimally fit the approximate force field equation, disregarding the physical cor­
rectness of individual values. This principle has been applied on a small scale since the 
very beginning of molecular dynamics simulations: The attractive R-6 term in the Len- 
nard Jones 12-6 potential is typically a factor 2 larger than suggested by experimental 
or theoretical data - which is meant to cancel the error caused by neglecting any higher 
order R-8 and R-10 terms24. With the Monte Carlo search method described here, it was 
possible to extend this idea to the entire force field.
The improvement in force field accuracy was equally large in the optimization 
and validation sets (Figure 7). This result is most likely due to the large optimization 
set with 50 proteins and no restrictions on the number of residues (the largest protein 
being 1C0P-A with 363 amino acids). The force field parameters thus did not "memo­
rize" any features specific to the optimization set.
The composition of optimization and validation sets has been influenced by two 
arbitrary choices: first we split them into 25 structures and 25 homology models, and 
second we decided to use only models without insertions or deletions. The latter 
choice was made to assure that a signal of progress due to backbone shifts of secon­
dary structure elements (which are the hardest to predict) was not masked by an im­
provement in loop modeling. To make sure that these choices did not reduce the range 
of application (e.g. to models without insertions or deletions), we continued the search 
procedure with models alone and structures alone (25 proteins each) for another 500 
steps. Our remarkable finding was that the all-atom RMSDs decreased only by an in­
significant amount of 0.003 A (model optimization set) and 0.008 A (structure optimi­
zation set). This means that keeping a structure in its minimum and improving a model 
requires the same force field parameters. It also implies that the force field parameters 
do not depend on the structural characteristics o f  the models (the number of inser­
tions, deletions etc.), and the algorithms used to build the models. The parameters 
simply provide an accurate description of protein structure.
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It also became clear that the ability not to make a high resolution structure worse 
is a crucial feature: One of the main force field applications is the calculation and 
comparison of energies (Figure 10). For an all-atom force field, this only makes sense 
after an extensive, unrestrained energy minimization (otherwise bumps and bond 
lengths or angles that are slightly off, add a huge, random factor to the force field en­
ergy that makes structure comparisons impossible). If a structure is significantly dis­
torted during the minimization, the whole procedure becomes questionable.
Comparing the initial and optimized values, we observed the smallest changes in 
experimentally and theoretically well determined parameters (bond stretching force 
constants changed by only 1%), while large shifts occurred in the less precisely known 
parameters (e.g. Van der Waals interactions).
We found that the current model improvement of 0.111 Ä is limited by the simu­
lated annealing search rather than the force field accuracy. Future work will therefore 
include the development of a more flexible minimization algorithm. Getting 0.111 Ä 
closer to reality is a valuable achievement, as the best CASP predictions 
(http://PredictionCenter.llnl.gov) in homology modeling are often just a few hun­
dredths of an Angstrom ahead of the competitors.
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In the preceding chapter, we systematically o p ­
timized the NOVA force field param eters while 
energy-minimizing proteins. These proteins were 
stand-alone structures as deposited in the Pro­
tein Data Bank, which a re  not exactly the same 
as the “real” structures observed experimen­
tally: in X-ray diffraction one analyzes com­
plete crystals, that contain lots of symmetry con­
tacts between individual proteins as well as in­
visible entities like hydrogen atoms or disor­
dered  waters and ions. All these complications 
have to be considered if the goal is a  physi­
cally realistic force field. The first required step 
is described in the following chapter: How to 
predict the presence of invisible hydrogen a t ­
oms a t ionizable amino acid side chains in crys­
tals.
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Protein pKa Prediction by 
Ewald Summation
Elmar Krieger, Jens E. Nielsen, Chris A.E.M. Spronk and Gert Vriend 
Abstract
We recently showed that the accuracy of empirical energy functions can be in­
creased by a systematic optimization of force field parameters using tens of thousands 
of short simulations on proteins with known X-ray structure. Further improvement of 
this method would require to simulate complete protein crystals rather than the stand­
alone proteins used so far. This would allow to consider all the interactions giving rise 
to the experimentally observed structure when optimizing the parameters. In crystal 
simulations, electrostatics, and thus the pKa values of ionizable groups, are even more 
important than in solution, especially as crystal structures are often solved at low pH. 
We therefore designed a fast method for pKa prediction in protein crystals.
pKa calculations for macromolecules are normally performed by solving the Pois- 
son-Boltzmann equation, accounting for the different dielectric constants s of solvent 
and solute, as well as the ionic strength. The values of s are still a point of debate, but 
good results have been achieved with s values of 20 and 80 for protein and water, re­
spectively. Since they differ by only a factor of four, we reason that it might be possi­
ble to use a single global dielectric constant, which would allow to base the calcula­
tions on the Ewald summation method. We define an empirical equation that ex­
presses the pKa as a function of electrostatic potential, hydrogen bonds and accessible 
surface area, and use a set of 217 experimentally determined pKas to optimize the 
proportionality constants. Despite its simplicity, this pKa calculation method reaches a 
high overall accuracy, while being fast enough to be used at each time-step of a mo­
lecular dynamics simulation. More importantly, the use of Ewald summation allows 
for improvements of molecular dynamics force field parameters by simulating proteins 
in their appropriate crystal environment.
Introduction
The prediction of pKa values in proteins has made considerable progress over the 
last years1,2. The Poisson-Boltzmann equation (PBE) has become an important tool 
because it allows the calculation of the electrostatic potential in a heterogeneous sol­
ute-solvent system, taking into account dielectric boundaries and the ionic strength. 
Initial approaches to electrostatic calculations were based on rough approximations 
like spherical proteins3. The ability to solve the Poisson-Boltzmann equation for arbi­
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trarily shaped proteins4-6 cleared the path for a range of successful applications, such 
as studies of enzymatic activity7, pH-dependent conformational changes8 and protein 
stability9-11. These algorithms, however, are computationally expensive, and conse­
quently led to the development of several simplified algorithms that avoid solving the 
PBE. Examples of these algorithms are the Debye-Hueckel approach12 and the electro­
static screening functions13,14.
pKa calculations have always focused on proteins in their physiological environ­
ment, matching the experimental determination of pKa values, which is also done in 
solution using NMR spectroscopy. However, the quality of pKa calculations depends 
heavily on the availability of high resolution protein structures. NMR structures of 
sufficient resolution are often not available, and one is forced to predict solution pKa 
values using X-ray structures. Much effort has been devoted to determining the re­
gions of structural divergence, excluding residues involved in crystal contacts15, opti­
mizing X-ray structures16 and incorporating information on protein flexibility17.
The goal is pKa prediction in protein crystals
The approach presented here has been developed due to a lack of solutions for a 
problem that appears paradoxical, given the facts mentioned above: the prediction of 
pKa values in protein crystals. Because of the crystal packing interactions, these pKas 
certainly differ from those measured in solution. The reason for addressing this prob­
lem becomes clear in view of recent developments in force field research. Thanks to 
the virtually unlimited resources provided by distributed computing systems like 
Models@Home18, it became feasible to use complete proteins instead of small mole­
cules as optimization targets when fitting the force field parameters19. This was done 
by randomly changing force field parameters and running simulations on a series of 
protein structures to see if the parameter changes would be beneficial. Obviously, the 
protein structures in the optimization set should be as realistic as possible, otherwise 
the force field might memorize features that are just structural artifacts. This can be 
achieved by taking high resolution X-ray structures and reconstructing the entire unit 
cell, including water molecules, counter ions and all solute hydrogens. The correct 
placement of polar hydrogens is especially important, and in addition to optimizing 
the hydrogen-bond network20, this requires the pKa values of all ionizable residues in 
the protein crystal and the pH at which the protein was crystallized. The force field 
parameters are then optimized in crystal space, so that all the interactions responsible 
for the experimentally observed structure can be considered. Because crystal and solu­
tion environments obey the same laws of physics, the optimized force field can be 
used in both.
76
Ewald summation captures the periodic environment
Electrostatic calculations in periodic crystal systems are complicated by the infi­
nite number of interactions. A clever way of making the problem tractable is Ewald 
summation21, which allows the calculation of the potential due to the N particles in the 
unit cell and an infinite number of periodic replicas. The method combines a rapidly 
converging short-range term with a long-range component evaluated in reciprocal 
space22. If the reciprocal sum is calculated using a particle-mesh approximation, the 
resulting Particle Mesh Ewald (PME) algorithm23 is considerably faster than the stan­
dard Ewald method. PME is part of almost every molecular dynamics program, and 
forms the basis for this work. The reciprocal sum provides the solution to Poisson's 
equation with periodic boundaries, Gaussian charge distributions and a single dielec­
tric constant. It thus lacks the two advantages of the Poisson-Boltzmann equation: im­
plicit counter ions and different dielectric constants for solvent and solute.
In an extensive optimization study, Demchuck & Wade2 determined that the best 
dielectric constant for solvent exposed residues is close to the one of water (80), while 
the protein interior should be assigned a value in the range of 10 to 20. Since 20 dif­
fers from 80 only by a factor of 4, we hypothesized that a single global dielectric con­
stant could suffice for accurate predictions, provided that some additional structural 
information was incorporated to account for the simplification.
The pKa can be approximated as a function of electrostatic potential, hy­
drogen bonds and accessible surface
Using simplified physical considerations and some modeler's experience, we de­
fined three rules of thumb for pKa prediction. The first and partly the second rule have 
also been mentioned in a recent analysis of carboxyl pKa values24:
•  If an ionizable group is surrounded by negatively charged residues, corresponding 
to a negative electrostatic potential, protonation becomes easier, the pKa increases. 
Similarly, if there are positively charged residues around, the pKa decreases. As a first 
approximation, the pKa shift is thus assumed to be proportional to the electrostatic 
potential.
•  If an ionizable group accepts hydrogen bonds, the space to place a proton is re­
duced, protonation becomes harder, and the pKa decreases. If after protonation, the 
group can donate a bond, protonation is favorable, the pKa increases.
•  If a group accepts hydrogen bonds and is buried, the pKa is decreased even fur­
ther, because the side-chain cannot facilitate protonation by moving to a different con­
formation where it does not receive hydrogen bonds. If a buried group can donate a 
hydrogen bond after protonation, the pKa increases, because there is no space for wa-
77
ter molecules that could ease the energetic cost of two hydrogen bond acceptors facing 
each other.
These three assumptions were fused into an empirical equation relating the pKa 
of a residue with the electrostatic potential, the number of hydrogen bonds and the 
accessible surface area:
pKa = ModelpKa + ^ [ -  [  * EwaldEi + B  * HBi ] + Sign(HBSum) * C * SurfaceLoss
Ionizable atoms
(Equation 1)
In this equation, Model pKa is the standard pKa value of a certain residue type, 
EwaldEi is the reciprocal space portion of the Ewald energy of a charge +1 at the loca­
tion of the ith ionizable atom in the residue (in kcal/mol), HBi is the difference between 
(potentially) donated and accepted hydrogen bonds at the ith atom, HBSum is the sum 
over all HBi, and SurfaceLoss is the loss of accessible surface area of the side-chain 
with respect to a fully exposed state. A, B and C are empirical proportionality con­
stants. The four unknown parameters Model pKa, A, B and C are globally optimized 
for each amino acid type so that the RMSD between predicted and observed pKa val­
ues is minimal. More details about the equation can be found in the Materials & 
Methods section.
The RMSD was chosen as optimization target because it is ideally suited for ana­
lyzing pKa prediction accuracy: one is not so much interested in the small shifts of 
isolated surface residues, but in the large shifts that significantly influence the protona­
tion states and dominate the RMSD when mispredicted. As the main goal of this work 
is to develop a method for pKa prediction in protein crystals used in force field param­
eterization, all residues are equally important. No matter if a wrong protonation state is 
assigned to an active site residue or to a surface residue involved in crystal contacts -  
the influence on the optimized force field is equally bad. Hence the RMSD is calcu­
lated for all residues with experimentally determined pKa values, and our goal is to 
obtain a low overall RMSD.
When fitting the parameters to reproduce experimental pKa values, it is important 
to note that these pKa values were measured in solution. The Ewald energy in equa­
tion 1 must therefore also be calculated in a solution environment. This is achieved by 
placing an isolated protein in a very large cell, so that the periodic boundaries implied 
by the Ewald summation have no significant influence.
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Methods
Datasets of experimental pKa values
A total of 227 experimentally measured pKa values were compiled for this study. 
They consisted of the Asp/Glu specific dataset collected by Forsyth et al.24, from 
which we removed double occurrences of the same protein to prevent compromising 
the jack-knife test, and four cases where it was uncertain if the structure deposited in 
the PDB was close to the one used for the pKa measurements: CD2 because it under­
goes domain swapping (see PDB IDs 1CDC and 1HNG), chymotrypsin inhibitor 2, 
because 19 important N-terminal residues were disordered in the structure, subunit C 
of F0F1-ATPase because its structure was determined in a chloroform-methanol mix­
ture and HIV-1 protease/KNI-272 complex because there were no force field parame­
ters available for the essential ligand. Then the histidine specific dataset from Edg- 
comb&Murphy25 and our own previously described collection15 were included, which 
added mainly pKa values for lysines and tyrosines. Too few pKa values of carboxyl- 
termini were available to be included in this analysis, which lead to slightly different 
RMSDs in Table III compared to our previous work15.
Hydrogen bond counting
The numbers of accepted and donated hydrogen bonds contributing to HBSum in 
equation (1) were determined after an optimization of the hydrogen-bond network 
with WHAT IF20, which was previously shown to significantly improve pKa predic­
tion accuracy15. A hydrogen bond was allowed to contribute to HBSum if the distance 
between the hydrogen and the acceptor was below 2.5 A and donor and acceptor were 
separated by more than three covalent bonds. For carboxyl oxygens and histidine ni­
trogens that were not protonated in the optimized network, a (potentially) donated 
bond was counted if there was an acceptor separated by more than three bonds within 
3.5 A.
Calculation of the electrostatic potential
EwaldE in equation (1) was calculated using the PME algorithm23 implemented in 
YASARA (available from www.YASARA.org, including the pKa prediction module 
described here). To avoid singularities and short-range noise, all calculations were 
done with the reciprocal part of the Ewald sum only, with a grid spacing <1A, 6th or­
der B-splines and a tolerance of 1e-5 for the direct space sum (which was used to de­
termine the convergence parameter for the reciprocal sum). The simulation cell was 
30A larger than the protein along each axis. Charges were assigned to all atoms based 
on the Amber 99 force field26. All ionizable groups were in their standard protonation 
states (i.e. D, E and H deprotonated, K and Y protonated), no iterations to sample dif­
ferent protonation patterns were done. For lysine and tyrosine, the potential was calcu­
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lated at the protonated NZ and OH atoms, for histidine at the deprotonated NE2 atom, 
and for aspartate and glutamate at both deprotonated oxygens (for the latter two resi­
dues, the sum in equation 1 therefore runs over two atoms). As the histidine ring can 
flip, the NE2 atom was assigned based on the following rules: 1) If the histidine ac­
cepts a hydrogen bond, the acceptor is the NE2 atom. 2) If the histidine donates a 
bond, the other nitrogen is labeled NE2. 3) If neither the first nor the second is true, 
both nitrogens are temporarily protonated and the one with the higher electrostatic po­
tential is assumed to be NE2.
Accessibility calculations
The loss of accessible surface area was calculated by subtracting the side-chain 
accessibilities calculated with WHAT IF's standard parameters27 from the following 
values corresponding to a fully exposed state: Asp 34A2, Glu 40A2, Tyr 60A2, His 
51A2, Lys 55A2.
Results and Discussion
To evaluate the accuracy of the Ewald summation approach, pKa predictions were 
made for 227 aspartate, glutamate, histidine, lysine and tyrosine residues in a set of 27 
structures. For the remaining ionizable side-chain types, we did not have enough ex­
perimental data to fit the parameters in equation 1.
Table I: Prediction accuracy for 227 
experimentally determined pKas. The
second column lists the number of predic­
tions per residue type. The RMSDs ob­
tained with the optimized null-model are 
shown in the third column. The fourth 
column lists the results obtained if only 
three parameters are used (parameter C in 
the equation 1 set to zero). Only six tyro­
sine residues were present, which was not 
enough to reliably fit more than one pa­
rameter (the model pKa). RMSDs for ty­
rosine are therefore identical in all cases. 
For the 22 lysine residues, only three pa­
rameters could be fit, giving the same re­
sults in the fourth and fifth column.
The RMSDs of the predicted pKa values from the experimental ones are listed in 
Table I. All RMSDs, including the one for the null-model, have been obtained with a 
Jack-knife approach, i.e. the parameters were separately determined for each of the 27 
structures using the remaining 26 structures.
Residue
Type
No. Null
Model
Ewald, 3 
Parame­
ters
Ewald, 4 
Parame­
ters
Asp 83 0.948 0.739 0.710
Glu 81 0.717 0.673 0.678
His 35 1.563 1.636 1.592
Tyr 6 0.837 0.837 0.837
Lys 22 0.502 0.399 0.399
All 227 0.965 0.899 0.879
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One important question is whether or not a pKa prediction method performs bet­
ter than the null-model, which trivially assumes a constant pKa value for all residues 
of a certain type, and can be surprisingly difficult to beat15. As can be seen from Table
I, our empirical equation gives better overall results (0.879) than the null-model 
(0.965). The best results are achieved for aspartate (0.71 compared to 0.95), while his­
tidine turns out to be the most difficult residue (1.59 compared to 1.56).
It has been noted before that there is virtually no correlation between accessible 
surface area and pKa shift24,25. Indeed, the surface term of our equation makes the 
weakest contribution and can be left out without significantly compromising the accu­
racy. This is shown in the fourth column of Table I (overall RMSD 0.899).
Table II lists three different parameter sets: The null-model alone, the parameters 
for equation (1) without the surface term (C set to zero), and the parameters for the 
complete equation (1). It can be seen that without the surface term, parameters have a 
clear physical meaning. E.g. accepting a hydrogen bond lowers the pKa of aspartate 
by 0.3 units, and the one of glutamate by 0.17 units. This matches the previous finding 
that pKa values of glutamates are less influenced by hydrogen bonds24. One simple 
explanation might be that the glutamate side-chain is more flexible, so rather than be­
ing protonated while accepting hydrogen bonds, it adapts a different conformation.
Residue
Type
Model
1
Model
3
A B Model
4
A B C
Asp 3.220 3.280 0.00264 0.3032 3.270 0.00254 0.4725 -0.01663
Glu 4.090 3.949 0.00209 0.1670 3.904 0.00224 0.2883 -0.01145
His 6.200 5.942 0.01112 0.7447 5.871 0.01002 -1.1772 0.05323
Tyr 10.800 10.800 - - 10.800 - - -
Lys 10.760 10.938 0.00408 0.0924 10.941 0.00424 -0.0042 0.00479
Table II: Empirical parameters for pKa prediction. The table shows three different sets 
with an increasing number of parameters. In the first case, only the model pKa is optimized, 
resulting in the null-model (pKa values in column 2). If additionally the electrostatic potential 
and the hydrogen bonds are considered, three parameters are required (columns 3 to 5). Inclu­
sion of the surface term requires four parameters (columns 6 to 9). A, B and C are the parame­
ters used in equation 1. The lack of data for tyrosin allowed to fit just one parameter, the model 
pKa.
As soon as the surface term is included, we find parameter dependencies that 
make a physical interpretation hardly fruitful (e.g. the sign of one parameter changes 
unexpectedly, while another one compensates). Because the accessibility calculations
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also consume most of the computing time (which becomes relevant when used at 
every step of a molecular dynamics simulation), not much is lost if they are left out. 
This finding does not indicate that desolvation effects are unimportant, it just shows 
that the surface term cannot truly capture their physical basis. Nevertheless, the sur­
face term passed the Jack-knife test, indicating that the increase of accuracy is not just 
due to the additional optimization parameter, but that there is indeed a small signal 
present.
Comparison of these results with other prediction methods is difficult, because 
they are very dataset dependent (e.g. the relatively high RMSD for aspartate is mainly 
caused by Asp-26 in Thioredoxin, with a predicted pKa of 3.5 and a measured pKa of 
8.128). We therefore calculated RMSDs for a subset of residues, matching the dataset 
used in our previous analysis based on the Poisson-Boltzmann equation15, which com­
pared favorable to other commonly used pKa calculation methods. Table III shows 
that the empirical approach works surprisingly well, giving lower RMSDs in all cases. 
The optimized null-model also performs better than expected.
Residue
Type
No. Null
Model
Ewald, 3 
Parameters
Ewald, 4 
Parameters
Poisson-
Boltzmann
Asp 45 0.847 0.592 0.573 0.733
Glu 41 0.802 0.777 0.788 0.970
His 8 1.591 1.318 1.206 1.588
Tyr 6 0.837 0.837 0.837 0.972
Lys 22 0.502 0.399 0.399 0.533
All 122 0.853 0.714 0.699 0.882
Table III: Comparison of pKa prediction accuracy for four different methods: the null­
model (column 3), the empirical equation described here, without (column 4) and with (column 
5) the surface term, and finally the Poisson-Boltzmann equation based approach described pre- 
viously15. Listed is the RMSD between predicted and experimentally measured pKa.
Conclusions
While the initial motivation for this work was the need to predict pKa values in 
protein crystals, we ended up with three interesting findings.
First, our empirical approach based on a global dielectric constant and hydrogen 
bond counting resulted in a lower RMSD than the PBE based method. Partly, this can 
be attributed to the parameter fitting procedure, which allows us to find optimum val­
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ues for variables that are difficult to determine, both theoretically and experimentally. 
PBE calculations also provide room for improvement by parameter optimization. This 
has already been shown for the dielectric constants2 and the hydrogen bonding net- 
work15, while the next obvious candidates are the model pKa values. These are crucial 
parameters, and estimating them from compounds that only resemble amino acids car­
ries the inherent danger of a systematic error. No physical meaning is lost if they are 
optimized instead. Another important reason for the lower RMSD is fewer mispredic­
tions. Due to its quadratic nature, the RMSD is dominated by the large mispredictions. 
We found that the PBE method occasionally predicts large pKa shifts that are not ob­
served experimentally. While it is sometimes suggested that pKa prediction should 
only look at residues that exhibit large shifts and not bother about the rest, this finding 
shows that all residues are important: a lot can be learned from analyzing why theory 
predicts a shift if none is found experimentally.
Second, the null-model is still hard to beat, as long as it is optimized and not as­
sumed to be equal to pKa values of model compounds used in PBE calculations. E.g. 
the optimum null-model pKa for aspartate is 3.22 (Table II). This differs by ~0.8 pKa 
units from the value used in PBE calculations15. When comparing prediction accura­
cies with the null-model, it is essential to use the optimized values, so that the null­
model gets a fair chance.
Third, our decision to evaluate the electrostatic potential only once, with every 
residue in its common protonation state, and to ignore the varying interactions due to 
the infinitely many permutations of protonation patterns, turned out surprisingly non­
fatal. While this can in principle not reproduce titration curves of tightly coupled ac­
tive site residues, the high overall accuracy makes our empirical approach well suited 
for its intended purpose: the rapid large scale prediction of pKa values and assignment 
of protonation states in force field parameterization, molecular dynamics simulations 
and homology model refinement.
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With the help of the pKa calculation method just
described, it becomes possible to predict what 
the protein crystals contained when the X-ray 
diffraction experiment was performed. This in 
jrn forms the basis for a new physically realis- 
force field derived like NOVA: YAMBER
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Abstract
Today’s energy functions are not able yet to distinguish reliably between correct 
and almost correct protein models. Improving these near-native models is currently a 
major bottle-neck in homology modeling or experimental structure determination at 
low resolution. Increasingly accurate energy functions are required to complete the 
'last mile of the protein folding problem', for example during a molecular dynamics 
simulation.
We present a new approach to reach this goal. For 50 high resolution X-ray struc­
tures, the complete unit cell was reconstructed, including disordered water molecules, 
counter ions and hydrogen atoms. Simulations were then run at the pH at which the 
crystal was solved, while force field parameters were iteratively adjusted so that the 
damage done to the structures was minimal. Starting with initial parameters from the 
AMBER force field, the optimization procedure converged at a new force field called 
YAMBER (Yet Another Model Building and Energy Refinement force field), which is 
shown to do significantly less damage to X-ray structures, often move homology 
models in the right direction and occasionally make them look like experimental struc­
tures.
Application of YAMBER during the CASP5 structure prediction experiment 
yielded a model for target 176 that was ranked first among 150 submissions. Due to its 
compatibility with the well established AMBER format, YAMBER can be used by 
almost any molecular dynamics program. The parameters are freely available from 
www.yasara.org/yamber .
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Introduction
Thanks to the exponential growth in processing power, the atomistic simulation of 
proteins has become feasible on personal computers, allowing scientists to routinely 
analyze internal motions1,2 or the effects of point mutations on protein stability3. Be­
cause accurate quantum chemical calculations take orders of magnitude too long, such 
simulations are based on empirical energy functions, like the AMBER4, CHARMm5 or 
GROMOS6 molecular dynamics force fields.
While many questions can be answered by today’s force fields, the biannual 
CASP meetings regularly show that one major goal has not been reached yet: the suc­
cessful refinement of homology models7. With structural genomics producing a rap­
idly growing number of templates for homology modeling8-10, bridging the accuracy 
gap between homology models and high resolution X-ray structures becomes increas­
ingly important. However, in close proximity to the native structure (0.5 - 2 A Ca 
RMSD), energy functions lose their discriminative power due to the often very small 
structural and energetic differences involved11. As a conclusion, highest force field 
accuracy is required when refining homology models12.
Fitting force field parameters is a very tedious task, usually involving quantum 
chemical calculations on small molecules13,14. And even perfectly accurate parameters 
cannot guarantee success, because the mathematical form of the energy function is an 
approximation by itself. Recently, we demonstrated a property we call 'force field 
equivalence': the force field parameters that performed best at improving homology 
models were virtually the same as those that did minimum damage to real structures 
during an energy minimization15. While it takes nanosecond simulations to check if a 
homology model improves during a molecular dynamics run, only picoseconds are 
required to minimize a real experimental structure. 'Force field equivalence' thus al­
lows to gain a factor of 1000 in computing time when judging the suitability of a force 
field for model refinement. This in turn permits to increase force field accuracy with a 
rather uncompromising approach: a 'self-parameterizing force field', the parameters of 
which are iteratively optimized to minimize the damage done to a training set of high 
resolution X-ray structures during a simulation15. This method leads to a consistent set 
of parameters that optimally fit the given force field equation.
It is obvious that the protein structures in the training set should be as close to re­
ality as possible, otherwise the force field might learn to reproduce features that sim­
ply do not exist. Here we describe a novel way of achieving that: the large-scale re­
construction of crystallographic unit cells, including disordered water molecules and 
counter ions, as well as hydrogen atoms. The latter turned out to be especially impor­
tant, as can be seen from Figure 1. This example shows the unit cell of a ribonuclease
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F1 crystal (PDB16 ID 1FUS17), with the side-chain carboxyl group of residue Glu 46 
contacting the backbone of residue Phe 100. This close contact of one carboxyl- and 
one backbone oxygen is very unfavorable, unless there is a proton trapped in between. 
If the force field was optimized without this proton present, it would memorize a 
completely unrealistic interaction pattern. In addition to a hydrogen-bonding network 
optimizer18, a new method for pKa prediction in protein crystals was required to assign 
the protonation states of ionizable groups.
Figure 1: Reconstructed unit cell of PDB entry 1FUS, containing four chains of ribonuclease 
F1. The magnified area on the right shows residue Glu 46 contacting the backbone of Phe 100. 
The predicted pKa for Glu 46 is 4.1, while the protein was crystallized at pH 3.5, making a 
protonation very likely. A predicted sodium counter-ion is also shown. Image created with 
YASARA.
Optimizing a force field in crystal space makes sure that all the forces giving rise 
to the experimentally observed structure are also present during the simulation and can 
be considered when fitting the parameters. As the physics acting in a crystal are the 
same as in solution, the resulting force field can be used in both environments.
Methods
Reconstruction of crystallographic unit cells
Using the PDBFINDER database19, all X-ray structures without uncommon 
ligands and with unit cells smaller than 260000 Â3 and were selected. From these, a 
non-redundant set (30% sequence identity cutoff) was extracted and sorted by a com­
bined resolution/R-factor quality indicator20. The top 50 structures were chosen and
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divided into optimization (even numbers) and validation sets (uneven numbers). For 
every structure, WHAT IF21 was run to add symmetry related chains based on the 
spacegroup information in the PDB file, and to optimize the hydrogen bonding net­
work18. Then YASARA was used to predict the pKa values of the ionizable groups in 
the crystal, assign their protonation states based on the pH at which the crystal was 
solved (retrieved from literature if not specified in the PDB file) and fill the cell with 
water. Water molecules in the original PDB files were kept if they were closer than 5 
Á to the protein. Using an iterative procedure, the AMBER99 electrostatic potential13 
was evaluated at all water molecules22, and the one with the lowest or highest potential 
was turned into a sodium or chloride counter ion, respectively, until the cell was neu­
tral. Then a startup simulation was run for 5 ps using the protocol described below, 
with all heavy protein atoms fixed, so that the solvent molecules could smoothly cover 
the protein surface. Finally a short steepest descent minimization of all atoms was 
done to remove severe bumps in the protein.
The 25 structures in the optimization set were 1et1, 1bqk, 1k1b, 1fus, 1ijv, 1ptf, 
1g2b, 1bd8, 1h75, 1ifc, 1ajj, 1aho, 1kf3, 1jo8, 1d4t, 1hyp, 1bkr, 1a62, 1faz, 1aac, 
1hcv, 2ovo, 1exr, 2erl and 1kth, the validation set consisted of 1psr, 2pth, 1ihr, 1g9o, 
1fux, 1qtw, 1eqt, 1jek, 2a0b, 1gk7, 1c7k, 1d0d, 1g2r, 2ygs, 1fl0, 1hka, 1g2q, 1im5, 
1gvp, 1hg7, 1i2t, 1f94, 2igd, 1cuo and 1gdu.
Simulations of crystals and models
All simulations were run with YASARA (www.yasara.org), using a multiple time 
step of 1 fs for intramolecular and 2 fs for intermolecular forces. A 7.9 Á cutoff was 
taken for Lennard-Jones forces and the direct space portion of the electrostatic forces, 
which were calculated using the Particle Mesh Ewald method23 with a grid spacing <1 
Á, 4th order B-splines and a tolerance of 10-4 for the direct space sum. Simulated an­
nealing minimizations started at 298K, velocities were scaled down with 0.9 every ten 
steps for a total time of five picoseconds. While it is tempting to let the unit cells relax 
during the energy minimizations and use the deviations as an additional force field 
quality indicator, we decided against it due to mainly two reasons: first, the required 
pressure calculations have been shown to be negatively influenced by the truncation of 
long-range Van der Waals interactions23, potentially leading to optimization artifacts 
in our case. Second, there is no unambiguous way of combining the unit cell deviation 
with the atomic RMSD to arrive at a single optimization progress indicator.
Molecular dynamics simulations of crystals24 were carried out at the temperature 
chosen during structure determination, the unit cells were again kept fixed (NVT en­
semble). Simulations of homology models were set up in the same way as the crystal 
simulations (with respect to the placement of water molecules, counter ions and opti­
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mization of the hydrogen bonding network to determine e.g. Histidine protonation 
states), with cells 13 A larger than the protein along each axis, and then run at 298K 
and constant pressure (NPT ensemble) to account for volume changes due to the much 
larger fluctuations of homology models in solution when compared to X-ray structures 
in a crystal environment. The temperature was adjusted using a Berendsen thermo­
stat25 based on the time-averaged temperature, i.e. to minimize the impact of tempera­
ture control, velocities were rescaled only about every ~100 simulation steps, when­
ever the average of the last ~100 measured temperatures converged. To allow a direct 
comparison, the 25 homology models were the same as in our previous study15. 
Calculation of RMSDs and B-factors
To reduce the amount of noise in the data, various precautions were taken. In Fig­
ures 2 and 3, all atoms with alternate locations in the original PDB file were excluded 
from RMSD calculations. In Figure 4, the models were scanned for flexible N- and C- 
terminal tails (Ca atoms that have less than x other Ca atoms within 7 A, where x=3 
for the first and last residue, x=4 for the second and second last, and x=5 for all other 
residues). Those tails were excluded, as well as three models in the upper half of Fig­
ure 4 that could not be expected to contribute useful data: 1RB9 and 451C because 
they contained an iron-sulfur cluster and a hem-group for which no suitable force field 
parameters were available, and 1BX7, because we found previously that there was no 
‘correct’ structure due to the protein’s high flexibility15.
B-factors were calculated from the last nanosecond of the simulation as described 
previously26, using only backbone atoms and ignoring the side-chains to avoid artifi­
cially high results caused by rotamer flips. Of the 25 crystals in the validation set, the 
20 structures that did not have backbone atoms with alternate locations were consid­
ered.
Results
Force field optimization
Initial force field parameters were borrowed from the AMBER99 force field, 
which has been shown earlier to be very accurate25. Because the total number of AM­
BER force field parameters is much larger than what can possibly be optimized, a sub­
set of 37 parameters was chosen (Table I). The majority of these (20) describe Van der 
Waals radii and contact energies, which are usually among the most difficult to pa­
rameterize. Nine parameters capture shifts in the charge distribution, and the remain­
ing eight relate to bonds, angles and torsions.
The parameters were optimized using a Monte Carlo search algorithm15. The 
quality of each parameter set was evaluated by a simulated annealing minimization of
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25 protein crystals. A lower RMSD from the initial structures meant higher quality. 
Due to the huge computational requirements of this procedure, the Models@Home 
distributed computing system was used26 (freely available from 
www.yasara.org/models).
YAMBER Optimization Parameters
Param. Description
1 Common scaling factor for bond stretching force constants
2 Common scaling factor for angle bending force constants
3 Scaling factor for Lennard-Jones forces between 1-4 bonded atoms
4 Scaling factor for electrostatic forces between 1-4 bonded atoms
5 Common scaling factor for all torsion energies excl. peptide bond
6 Energy barrier of the peptide bond
7 Improper dihedral barrier for carbonyl and carboxyl groups
8 Improper dihedral barrier for all other planar groups
9-24 VdW radii of the following AMBER atom types: H, HC, H1, HP, 
HA, H4, H5, O, OH, C, CA, CT, N, S, C0, Zn
25-28 VdW contact energies of hydrogen, carbon, nitrogen and oxygen
29 Charge shift c for N (+c) and H (-c) in peptide bonds
30 Charge shift c for N (+c) and H (-c) in aromatic NH groups
31 Charge shift c for N (+c) and H (-c/2) in NH2 groups
32 Charge shift c for N (+c) and H (-c/3) in NH3 groups
33 Charge shift c for O (+c), H (-2c/3) and C (-c/3) in hydroxyl groups
34 Charge shift c for C (+c) and O (-c) in carbonyl groups
35 Charge shift c for C (+c) and O (-c/2) in carboxyl groups
36 Charge shift c for C (+c) and H (-c/3) in methyl groups
37 Charge shift c for C (+c) and H (-c) in aromatic rings
Table I. The 37 optimization parameters of the YAMBER force field. Charge shift parameters 
are simply added to the AMBER charges, their distribution ensures that the overall net charge 
does not change.
The force field optimization progress is shown in Figure 2. From an initial value 
of 0.467 A measured after minimization with the AMBER99 force field, the RMSD 
dropped quickly during the first 250 parameter optimization steps, until it hit an ex­
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tended local minimum, from where it escaped around step 700. Then there was virtu­
ally no progress until step 1300, therefore we assumed convergence at 0.431 A. This 
force field is called 'YAMBER 1', and except for different parameters, it is still the 
same as AMBER. We then decided to switch bond length and angle parameters to the 
Engh&Huber dataset27, which required the introduction of 16 new atom types. This
was mainly done to pro­
vide a slightly different 
starting point in search 
space and to avoid small 
systematic deviations from 
the WHAT_CHECK28 
standard values. Indeed, 
we found another notice­
able improvement around 
step 1400, and finally 
stopped the procedure at 
step 1800, with an RMSD 
of 0.425 A. This resulting 
force field is referred to as 
'YAMBER 2'.
Force field evaluation
During the force field optimization procedure, the improvement at every step is 
very small. Consequently, simulated annealing runs had to be used, because the ran­
domness of a true molecular dynamics simulation at constant temperature completely 
masks the progress signal. To investigate how the reduction in simulated annealing 
RMSD affects the behavior of the two YAMBER force fields under 'real-life' condi­
tions, we ran molecular dynamics simulations of another 25 protein crystals, sharing 
less than 30% sequence identity with those in the optimization set. The simulation 
temperatures were the same as during experimental structure determination. As can be 
seen from the top part of Figure 3, the Ca RMSDs from the starting structure after 
1.25 nanoseconds are significantly lower for the YAMBER 1 (0.552±0.017 A) and 
YAMBER 2 (0.559±0.017 A) force fields, than for AMBER (0.657±0.018 A), which 
provided the initial parameters.
The horizontal line at 0.48 A marks the border of experimental uncertainty (i.e. 
the average RMSD observed if the same structure is solved at high resolution by dif­
ferent research groups and refinement programs15). As soon as the RMSD crosses this
Figure 2: Average heavy atom RMSD of 25 protein crys­
tals after 5 ps simulated annealing runs, as a function of 
force field optimization step.
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line, one can say that a structure got worse during the simulation. The optimization 
procedure therefore allowed to bridge ~60% of the gap between the maximum allowed 
RMSD and the initially measured RMSD.
One could argue that the RMSD of single snapshots is not the ideal indicator of 
force field accuracy, because the X-ray diffraction pattern provides only a time- 
averaged view of the pro­
tein. Consequently, one 
should compare it with the 
time-averaged structure in 
the simulation. We there­
fore superimposed the 
snapshots covering the last 
25% of the simulation on 
the X-ray structure and 
averaged the atom coordi­
nates. The resulting 
RMSDs are 0.611 for 
AMBER, and 0.506/0.517 
A for YAMBER1/2, which 
is only a small improve­
ment regarding the fact 
that the answer was implic­
itly given by providing the 
X-ray structure as a super­
position target. The indi­
vidual simulation snap­
shots are not equally 
spread around the true structure, but cluster at a different spot in conformational space, 
indicating that the source of the difference is indeed the force field accuracy.
Any parameter optimization procedure carries the inherent danger of producing 
artifacts. With the simulated annealing approach used here, the YAMBER force fields 
were trained to have stable energy minima as close to true structures as possible. An 
alternative view is that they were optimized not to move proteins away from the start­
ing structure, so one might ask if they move proteins at all. This question was an­
swered by measuring the RMSD between two consecutive simulation snapshots 
(saved in 5 ps intervals), which is a good indicator of protein flexibility. The bottom 
part of Figure 3 shows that all three force fields lie close together at 0.288±0.014
Figure 3: Molecular dynamics simulations of 25 protein 
crystals with three different force fields. Shown is the av­
erage Ca RMSD from the starting structure (upper part, 
indicating accuracy) and from the previous simulation 
snapshot 5 picoseconds before (lower part, indicating 
flexibility). YAMBER is shown in dark gray, YAMBER 2 
in black. The horizontal line at 0.48 A shows the limit of 
experimental uncertainty. Error bars were derived from 
the last 25% of the simulation by calculating the standard 
deviation for every protein and averaging over all proteins.
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(AMBER), 0.262±0.013 (YAMBER 1) and 0.263±0.013 A (YAMBER 2). The overall 
flexibility of proteins simulated with YAMBER is thus slightly smaller, but less than 
two standard deviations away from AMBER, while the accuracy increased by six 
standard deviations. To investigate this finding in more detail, we calculated the B- 
factors from the simulations and compared them to the experimental values. As ex­
pected, the in silico B-factors are lower, because 1 ns simulations are not enough to 
sample conformational space exhaustively (http://amber.scripps.edu/tutorial/integrase/ 
loop13.htm). The average B-factor is 17 for the experimental structures, 15 for AM­
BER and 11 for YAMBER1/2. While proteins simulated with YAMBER are thus in­
deed ‘stiffer’ on the 1 ns time-scale, they nevertheless show a better fit to the experi­
mental data: the RMSD between calculated and experimental B-factors is 25 for AM­
BER, 21 for YAMBER 1 and 20 for YAMBER 2.
Refinement of homology models
To evaluate the performance of YAMBER in model refinement, we ran simula­
tions for a set of 25 randomly chosen homology models, some of which are very simi­
lar to the target. We previ­
ously concluded that it 
does not make sense to 
indiscriminately refine all 
homology models. Only 
the more distant models, 
where template (X-ray) 
resolution divided by per­
centage sequence identity 
with the target is larger 
than 0.04, are good candi­
dates for successful re- 
finement15. 11 of the 25 
models match this criterion 
and can be simulated relia­
bly. The difference be­
tween these two sets is 
shown in Figure 4. As ex­
pected, one still cannot 
blindly run simulations for 
any model built. For the 
complete set, the Ca-RMSD from the targets increases during the unrestrained simula­
Figure 4: Molecular dynamics simulations of 25 homol­
ogy models in solution, using three different force fields. 
AMBER is shown in light gray, YAMBER in dark grey 
and YAMBER 2 in black. The average Ca-RMSD from 
the target is shown on the vertical axis, the dotted lines 
indicates the initial models before any refinement. The 
upper half shows a subset of 14 distant models, where 
template resolution divided by percentage sequence iden­
tity to the target is >0.04.
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tion: averaged over the entire simulation time (1.5 ns), it is 0.51 (AMBER) and 
0.38/0.37 A (YAMBER1/2) higher than the initial RMSD (bottom half of Figure 4). 
While a temporary increase in RMSD may be required by individual models to over­
come energy barriers, the fact that it happens immediately in the beginning and at a 
rather low starting RMSD of 1.35 A indicates that the reason for the jump is the same 
as in Figure 3 - a lack of force field accuracy. The subset of distant models is shown in 
the upper half of Figure 4. Because it is smaller, the average RMSD is influenced 
more strongly by the random noise inherent to molecular dynamics simulations. Nev­
ertheless, YAMBER 2 still performs best and actually can move models in the right 
direction, towards the target coordinates. After about 750 picoseconds, the YAMBER 
2 curve crosses the initial line again. However, this does not mean that models gener­
ally get worse after a certain simulation time. Closer inspection shows that after 750 
picoseconds, those models that can be improved reach a stable state, while the hope­
less cases continue to go in the wrong direction and eventually pull the average across 
the line (e.g. after 750 picoseconds, five of the eleven models still have a lower RMSD 
(by 0.190 A on average), and keep this improvement till the end of the simulation 
(0.193 A)).
The bad models can fortunately be identified using structure validation tools. 
During CASP5, we used WHAT_CHECK30 to pick out the pearls, and at least for tar­
get 176, our model was ranked first among 150 submissions 
(http://predictioncenter.llnl.gov/casp5/pubresult5/CASP_BROWSER/DATA.html/ 
3d_T0176_all.html).
Discussion and Conclusion
When looking at the final force field parameters, one obvious question is: which 
parameters changed and why? In a best case scenario, all parameter changes would 
seem random, indicating the absence of systematic errors in the initial force field as 
well as in the optimization procedure. And essentially this was the case: Van der 
Waals radii shifted up in six and down in eight cases, charges increased in five and 
decreased in three cases. Two systematic changes were noted however: the scaling 
factors for the Van der Waals and electrostatic forces between 1-4 bonded atoms 
shifted both down considerably (from 0.5 and 0.83 to 0.27 and 0.65, respectively), and 
the Van der Waals contact energies increased in all cases, almost doubling for hydro­
gen and carbon atoms. In the AMBER force field, hydrogen and carbon have a very 
small contact energy (0.015 and 0.09-0.11 kcal/mol) when compared to nitrogen 
(0.17) and oxygen (0.21). In YAMBER 2, carbon and nitrogen came out equal (0.19 
kcal/mol). This increase in Van der Waals attraction may explain the slightly lower
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flexibility of proteins simulated with the YAMBER force fields (Figure 3). An addi­
tional reason may be the backbone hydrogens bonds, which got stronger during the 
parameter optimization (in contrast to other hydrogen bonds involving side-chain hy­
droxyl and amino groups that got weaker).
The fact that YAMBER 2 performed best not only in its trained area, the minimi­
zation of protein crystals, but also in the quite different application of homology 
model refinement, reaffirms our previous finding that there is only one optimum set of 
force field parameters. Therefore it seems likely that the YAMBER force fields will be 
more generally applicable.
In our previous work, the top improvement we found for any model was 0.25 A15. 
We concluded that the problem was not the force field accuracy, but just the fact that 
the models 'got stuck' too early during the simulated annealing minimization. Here, we 
used molecular dynamics simulations to search conformational space, which are much 
less likely to get trapped in local minima, thereby raising our hopes for a significantly 
better result. An analysis of all 75 model trajectories yielded quite a surprise: the high­
est improvement was found for a protein G model, simulated with YAMBER 2. The 
Ca-RMSD dropped from an initial value of 1.74 A, which is typical for a close ho­
mology model, all the way down to 0.7 A, which corresponds to a medium-resolution 
X-ray structure. So at least in this case, we could observe the metamorphosis of a 
model to an experimental-like structure.
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While energy functions are probably the most 
important aspect of protein structure prediction, 
a lot more is required to build an actual model. 
The main steps are outlined in the introduction, 
and normally a human expert is needed so 
safely navigate around all the potential pitfalls 
along the path. As there are simply not enough 
experts to build all the models of interest, we 
developed Eliza, a program that tries to think 
like a human modeler. Having fed a sequence 
to Eliza, one not only receives the final model, 
but also a manuscript with a detailed explana­
tion of the individual steps and decisions.
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ELIZA -  an expert system for 
protein structure prediction
Elmar Krieger and Gert Vriend
Abstract
When building a model by homology, a lot o f steps have to be taken on the way 
from the initial sequence to the final three-dimensional model coordinates. At each of 
these steps, decisions are required that heavily influence the result: which are the best 
template structures? Should multiple templates be combined? Which is the optimal 
alignment? Where are potential alignment errors? Can some of these errors be cor­
rected by looking at the structural context? Is the alignment physically possible, or are 
there gaps in the template that cannot be spanned? Are all loops placed correctly? Is 
there a quartary structure, should the model be oligomerized? Does it make sense to 
refine at least some parts o f the model?
These are typical questions answered by Eliza, an expert system for structure pre­
diction, implemented using the Python scripting language. Eliza is part o f an object- 
oriented model environment that is transparently interfaced to the Models@Home 
cluster system. Eliza was developed during the initial phase o f CASP5, when we built 
models with lots o f manual interventions and added these thoughts and decisions to 
Eliza’s ‘brain’. Eliza has thus been trained to navigate around the typical pitfalls en­
countered during model building, with the aim to further reduce the quality gap be­
tween automated and expert predictions. As an integral part o f the process, Eliza gen­
erates a prediction report with a complete description of the individual steps and deci­
sions, as well as the reasoning behind them. This allows human experts to check and 
improve Eliza, while novice users can learn how homology modeling works in prac­
tice by the example o f their favorite protein.
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When combined with the tools described in 
chapter 2 and the energy functions developed  
in chapter 3, the expert system Eliza can turn 
initial raw-alignments obtained from servers on 
the web into actual protein models. These mod­
els can then be used to analyze experimental 
results, provide new structure-based insights 
and guide future experiments. This is done in 
tight collaboration with research groups work­
ing on ‘real’ problems in the fields of molecular 
biology or human genetics. Examples for these 
practical applications are given in the next 
chapter. As most of the work has been done by 
our collaborators, only the abstracts are in­
cluded on the following pages.
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In collaboration with Vincenzo Bonifati and Pe­
ter Heutink at the Department of Clinical 
Genetics, Erasmus Medical Center Rotterdam, 
w e modeled DJ-1 (shown above). Vincenzo 
located this protein while searching for the 
chromosomal location of an inheritable form of 
early-onset parkinsonism. This protein of still 
unknown function was found to contain a Leu > 
Pro mutation at position 1 66 , which according 
to the homology model is in the middle of a C- 
terminal alpha-helix. As proline cannot 
participate in helical hydrogen bonding, it is a 
strong helix breaker and consequently 
destabilizes the protein. It could be shown 
experimentally that the L166P mutant is 
degraded  much more rapidly than the wild­
type DJ-1 protein.
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Mutations in the DJ-1 gene associated 
with autosomal recessive early-
onset parkinsonism
Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MC, 
Squitieri F, Ibanez P, Joosse M, van Dongen JW, Vanacore N, van Swieten JC, Brice A, 
Meco G, van Duijn CM, Oostra BA, Heutink P.
Department of Clinical Genetics, Erasmus Medical Center Rotterdam, The Netherlands
Science (2003) 299:256-9.
The DJ-1 gene encodes a ubiquitous, highly conserved protein. Here, we show 
that DJ-1 mutations are associated with PARK7, a monogenic form of human parkin­
sonism. The function o f the DJ-1 protein remains unknown, but evidence suggests its 
involvement in the oxidative stress response. Our findings indicate that loss o f DJ-1 
function leads to neurodegeneration. Elucidating the physiological role o f DJ-1 protein 
may promote understanding of the mechanisms of brain neuronal maintenance and 
pathogenesis o f Parkinson's disease.
DJ-1, a novel gene for autosomal 
recessive, early onset parkinsonism
Bonifati V, Rizzu P, Squitieri F, Krieger E, Vanacore N, van Swieten JC, Brice A, van 
Duijn CM, Oostra B, Meco G, Heutink P.
Department of Clinical Genetics, Erasmus Medical Center Rotterdam, The Netherlands
Neurol Sci. (2003) 24:159-60.
Four chromosomal loci ( PARK2, PARK6, PARK7, and PARK9) associated with 
autosomal recessive, early onset parkinsonism are known. We mapped the PARK7 
locus to chromosome 1p36 in a large family from a genetically isolated population in 
the Netherlands, and confirmed this linkage in an Italian family. By positional cloning 
within the refined PARK7 critical region we recently identified mutations in the DJ-1 
gene in the two PARK7-linked families. The function o f DJ-1 remains largely un­
known, but evidence from genetic studies on the yeast DJ-1 homologue, and bio­
chemical studies in murine and human cell lines, suggests a role for DJ-1 as an anti­
oxidant and/or a molecular chaperone. Elucidating the role o f DJ-1 will lead to a better 
understanding of the pathogenesis o f DJ-1-related and common forms of Parkinson's 
disease.
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Trp 453
Trp 309
In a joint project with Ida van der Klei at Eu­
karyotic Microbiology, Groningen Biomolecular 
Sciences and Biotechnology Institute, we built a 
model for Pex5p (shown above), the receptor 
protein for the peroxisomal targeting signal 
peptide PTS-1. A dansylated PTS-1 derivative 
is bound to the model. The dansyl group al­
lowed to measure fluorescence resonance en­
ergy transfer from surrounding Trp residues. 
These results could be interpreted based on the 
model. In addition, a strong dependence of Trp 
fluorescence on the pH was found, suggesting 
the existence of different oligomeric Pex5p 
forms on the acidic inside and the neutral out­
side of the peroxisomal membrane. This could 
be the basis of the shuttle mechanism that re­
leases PTS-1 (and hence the translocated pro­
tein) on the inside.
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Fluorescence analysis of the 
Hansenula polymorpha peroxisomal 
targeting signal-1 receptor, Pex5p
Boteva R1, Koek A, Visser NV, Visser AJ, Krieger E, Zlateva T, Veenhuis M,
van der Klei I2.
institute of Molecular Biology, Bulgarian Academy of Sciences, Sofia, Bulgaria. 
2Groningen Biomolecular Sciences and Biotechnology Institute, The Netherlands 
Eur J Biochem. (2003) 270:4332-8.
Abstract
Correct sorting o f newly synthesized peroxisomal matrix proteins is dependent on 
a peroxisomal targeting signal (PTS). So far two PTSs are known. PTS1 consists o f a 
tripeptide that is located at the extreme C terminus o f matrix proteins and is specifi­
cally recognized by the PTS 1-receptor Pex5p. We studied Hansenula polymorpha 
Pex5p (HpPex5p) using fluorescence spectroscopy. The intensity o f Trp fluorescence 
of purified HpPex5p increased by 25% upon shifting the pH from pH 6.0 to pH 7.2. 
Together with the results o f fluorescence quenching by acrylamide, these data suggest 
that the conformation o f HpPex5p differs at these two pH values. Fluorescence anisot­
ropy decay measurements revealed that the pH affected the oligomeric state of  
HpPex5p, possibly from monomers/dimers at pH 6.0 to larger oligomeric forms at pH
7.2. Addition o f dansylated peptides containing a PTS1, caused some shortening of the 
average fluorescence lifetime of the Trp residues, which was most pronounced at pH
7.2. Our data are discussed in relation to a molecular model o f HpPex5p based on the 
three-dimensional structure o f human Pex5p.
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Together with John van Swieten and Peter 
Heutink at the Department of Neurology, EMC 
Rotterdam, w e built a model of fibroblast 
growth factor 14, shown above. A Phe 145 > 
Ser mutation was discovered in a family a f ­
fected by spinocerebellar ataxia, an inherit­
ab le  disease causing a degeneration of certain 
brain regions responsible for muscle coordina­
tion. According to the model, Phe 145 forms an 
integral part of the hydrophobic protein core, a 
mutation to Ser leaves an empty hole. Changes 
of this type are known to destabilize proteins. 
The expression pattern of fg f14  in mice sug­
a role in neuronal development and adult 
in function. It is thus very plausible that a 
reduction in stability can cause the observed 
phenotype.
gesl 
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A mutation in the fibroblast growth 
factor 14 gene is associated with auto­
somal dominant cerebellar ataxia
van Swieten JC, Brusse E, de G raaf BM, Krieger E, van de G raaf R, de Koning 
I, Maat-Kievit A, Leegwater P, Dooijes D, Oostra BA, Heutink P
Department o f Neurology, Erasmus Medical Center Rotterdam, The Netherlands.
Am J Hum Genet. (2003) 72:191-9
Abstract
Hereditary spinocerebellar ataxias (SCAs) are a clinically and genetically hetero­
geneous group of neurodegenerative disorders for which >=14 different genetic loci 
have been identified. In some SCA types, expanded tri- or pentanucleotide repeats 
have been identified, and the length o f these expansions correlates with the age at on­
set and with the severity o f the clinical phenotype. In several other SCA types, no ge­
netic defect has yet been identified. We describe a large, three-generation family with 
early-onset tremor, dyskinesia, and slowly progressive cerebellar ataxia, not associated 
with any o f the known SCA loci, and a mutation in the fibroblast growth factor 14 
(FGF14) gene on chromosome 13q34. Our observations are in accordance with the 
occurrence o f ataxia and paroxysmal dyskinesia in Fgf14-knockout mice. As indicated 
by protein modeling, the amino acid change from phenylalanine to serine at position 
145 is predicted to reduce the stability of the protein. The present FGF14 mutation 
represents a novel gene defect involved in the neurodegeneration o f cerebellum and 
basal ganglia.
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In collaboration with Theo Geijtenbeek at the 
Department of Molecular Cell Biology, VUMC 
Amsterdam, we modeled the C-terminal C-type 
lectin domain of the DC-SIGN protein. DC-SIGN 
plays a crucial role as HIV-1 receptor on the 
surface of dendritic cells. The interaction with 
sugars occurs at the left of the two Calcium 
binding sites shown above. As the HIV-1 target 
protein g p 1 2 0  is heavily glycosylated, one 
would expect it to bind in the same way as 
natural interaction partners like ICAM-3 — via 
the attached sugars. Surprisingly this turned out 
not to be the case: g p 1 2 0  affinity is not a f ­
fected by deglycosylation, indicating that there 
is a second, independent binding site for 
g p 120 . Inhibition of this interaction could thus 
prevent HIV infection while still allowing natural 
interactions to occur.
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Identification of different binding sites 
in the dendritic cell-specific receptor 
DC-SIGN for intercellular adhesion 
molecule 3 and HIV-1
Geijtenbeek TB, van Duijnhoven GC, van Vliet SJ, Krieger E, Vriend G, Figdor
CG, van Kooyk Y.
Department of Molecular Cell Biology, Vrije University Medical Center Amster­
dam, The Netherlands
J Biol Chem. (2002) 277:11314-20
Abstract
The novel dendritic cell (DC)-specific human immunodeficiency virus type 1 
(HIV-1) receptor DC-SIGN plays a key role in the dissemination o f HIV-1 by DC. 
DC-SIGN is thought to capture HIV-1 at mucosal sites o f entry, facilitating transport 
to lymphoid tissues, where DC-SIGN efficiently transmits HIV-1 to T cells. DC-SIGN 
is also important in the initiation o f immune responses by regulating DC-T cell inter­
actions through intercellular adhesion molecule 3 (ICAM-3). We have characterized 
the mechanism o f ligand binding by DC-SIGN and identified the crucial amino acids 
involved in this process. Strikingly, the HIV-1 gp120 binding site in DC-SIGN is dif­
ferent from that o f ICAM-3, consistent with the observation that glycosylation of  
gp120, in contrast to ICAM-3, is not crucial to the interaction with DC-SIGN. A spe­
cific mutation in DC-SIGN abrogated ICAM-3 binding, whereas the HIV-1 gp120 
interaction was unaffected. This DC-SIGN mutant captured HIV-1 and infected T 
cells in trans as efficiently as wild-type DC-SIGN, demonstrating that ICAM-3 bind­
ing is not necessary for HIV-1 transmission. This study provides a basis for the design 
of drugs that inhibit or alter interactions o f DC-SIGN with gp120 but not with ICAM-
3 or vice versa and that have a therapeutic value in immunological diseases and/or 
HIV-1 infections.
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In a joint-project with Andreas Kungl at the Insti­
tute of Pharmaceutical Chemistry and Pharma­
ceutical Technology, University of Graz, we 
docked heparin and interleukin-8 (IL-8). The in­
teraction of heparin and IL-8 is of key impor­
tance during inflammation. Experimental results 
indicated that one single long heparin 24mer 
might span both binding sites in dimeric IL-8 in a 
horseshoe-like fashion (Figure A). During a mo­
lecular dynamics simulation of such a complex, 
e interactions concentrated on two symmetry- 
related hot-spots (circles in Figure B). Key resi­
dues in these regions were mutated to alanine 
in vitro and in silico. Comparison of the meas­
ured and predicted binding energies showed 
good qualitative agreement.
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A structural and dynamical model for 
the interaction of interleukin-8 and 
glycosaminoglycans: support from iso­
thermal fluorescence titrations
Krieger E, Geretti E, Brandner B, G oger B, Wells TN and Kungl AJ
Institute of Pharmaceutical Chemistry and Pharmaceutical Technology, University o f G raz, Austria
Proteins (2004) 54: 768-775
Abstract
Binding of IL-8 to GAGs on the surface of endothelial cells is crucial for the re­
cruitment o f neutrophils to an inflammatory site. Deriving structural knowledge about 
this interaction from in silico docking experiments has proven difficult due to the high 
flexibility and the size o f GAGs. We therefore developed a docking method that takes 
into account ligand and protein flexibility by running ~ 15000 molecular dynamics 
simulations o f the docking event with different initial orientations o f the binding part­
ners. The method was shown to successfully reproduce the residues o f basic fibroblast 
growth factor involved in GAG binding. Docking o f a heparin hexasaccharide to ILD8 
gave an interaction interface involving the basic residues His18, Lys20, Arg60, Lys64, 
Lys67 and Arg68. By subjecting IL-8 single-site mutants, in which these amino acids 
were replaced by alanine, to isothermal fluorescence titrations the affinities for heparin 
were determined to be wtIL-8 > IL-8(H18A) >> IL-8(R68A) > IL-8(K67A) >> IL- 
8(K20A) > IL-8(R60A) >> IL-8(K64A). A comparison with the binding energies cal­
culated from the model revealed high values for wtIL-8 and the H18A mutant and sig­
nificantly lower but similar energies for the remaining mutants. Connecting the two 
fully sulfated hexasaccharides bound to each o f the two IL-8 monomers in the dimeric 
chemokine by an N-acetylated dodecasaccharide gave a complex structure in which 
the GAG molecule aligned in an parallel fashion to the N-terminal a-helices o f IL-8 
like a horseshoe. A 5 ns molecular dynamics simulation of this complex confirmed its 
structural stability and revealed a reorientation in both binding sites where a disaccha­
ride became the central binding unit. Isothermal fluorescence titration experiments 
using differently sulfated heparin disaccharides confirmed that a single disaccharide 
can indeed bind IL-8 with high affinity.
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Together with Pascal Duijf at the Department of 
Human Genetics, UMC Nijmegen, we analyzed  
a newly discovered mutation in the p63 protein 
linked to ADULT syndrome. p63 is a transcrip­
tion regulator of crucial importance. Previously 
described mutations all cluster around the alpha 
helix that docks in the major DNA groove and 
thus inhibit DNA binding. The new Arg 2 9 8  > 
Gln mutation is however located on the back- 
ide of the DNA binding domain, and was 
found to activate transcription. As only little is 
known about the precise arrangement of the 
activation complex, an explanation at the mo­
lecular level is currently not possible.
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Gain-of-function mutation in ADULf 
syndrome reveals the presence of a 
second transactivation domain in p63
Duijf PH, Vanmolkot KR, Propping P, Friedl W , Krieger E, McKeon F, Dotsch V,
Brunner HG, van Bokhoven H.
Department o f Human Genetics, University Medical Centre Nijmegen, The Netherlands.
Hum Mol Genet. (2002) 11:799-804
Abstract
The transcriptional co-activator p63 is o f crucial importance for correct develop­
ment o f the limbs, ectodermal appendages (skin, nails, teeth, hair, glands), lip and pal­
ate. Mutations in the p63 gene are found in a number of human syndromes, including 
ectrodactyly-ectodermal dysplasia-cleft lip/palate (EEC) syndrome, limb-mammary 
syndrome (LMS), Hay-Wells syndrome and in non-syndromic split-hand/split-foot 
malformation (SHFM). Each syndrome has a specific pattern of mutations with differ­
ent functional effects in in vitro functional assays. We report a mutation R298Q in 
acro-dermato-ungual-lacrimal-tooth (ADULT) syndrome, another EEC-like condition. 
The mutation is located in the DNA binding domain of p63, which harbors almost all 
EEC associated mutations. However, unlike mutations in EEC syndrome, the R298Q 
ADULT syndrome mutation does not impair DNA binding. Rather, the mutation con­
fers novel transcription activation capacity on the DeltaN-p63gamma isoform, which 
normally does not possess such activity. These results confirm that ADULT syndrome 
is a clinically as well as molecularly distinct member o f the expanding p63 mutation 
family o f human malformation syndromes. Our results further show that p63 contains 
a second transactivation domain which is normally repressed and can become acti­
vated by mutations in the DNA binding domain of p63.
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In collaboration with Jan Koenderink and Jan 
Joep d e Pont at the Department of Biochemis­
try, Nijmegen Center for Molecular Life Sci­
ences, we built a model for the E2 form of H,K- 
ATPase. The model revealed one strong potas­
sium binding site in close proximity to a salt- 
bridge between Lys 791 and Glu 820. A large 
number of mutations was analyzed with respect 
to this model, most interesting of which is a 
E820Q exchange. In the model, this mutation 
disrupts the salt-bridge and lets Lys 791 take 
e place of the potassium ion. This would e x ­
plain the experimental finding, that the mutant 
enzyme functions also in the absence of potas-
sium.
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A conformational specific interhelical 
salt bridge is essential for the E2 
preference of gastric H,K-ATPase
Koenderink JB, Swarts HGP, Willems PHGM, Krieger E and De Pont JJHHM
Department of Biochemistry, Nijmegen Center for Molecular Life Sciences,
The Netherlands 
J Biol Chem. (2004) 279:16417-16427
Abstract
Homology modeling of gastric H,K-ATPase based on E2- model of 
sarco(endo)plasmic reticulum Ca2+-ATPase revealed the presence o f both a single 
high-affinity binding site for K+ and a E2-form specific salt bridge between Glu820 
(M6) and Lys791 (M5). Replacement o f Lys791 by an Ala residue significantly re­
duced the K+ affinity, without altering the E2-preference o f the enzyme. Replacement 
of Glu820 by a Gln residue rendered the enzyme active in the absence o f K+ with 
preference for the E1-conformation. The double K791A-E820Q mutant had no AT­
Pase activity but showed a preference for the E2-conformation reaction as measured 
by the effect o f specific inhibitors on the phosphorylation reaction. Modeling o f the 
E820Q mutant revealed that the head group of the Lys residue together with a water 
molecule fills the K+-binding pocked, thus explaining the K+-independent activity of 
this mutant. These data indicate that the salt bridge is essential for high-affinity K+ 
binding and E2-preference o f H,K-ATPase. Moreover, its breakage provides a struc­
tural explanation for the K+-insensitive activity and E1-preference o f the E820Q mu­
tant.
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In a joint project with Hannie Kremer and Erwin 
van Wijk at the Department of Otorhino­
laryngology, UMC Nijmegen, we investigated a 
Thr > Ile mutation in the gamma actin 1 gene of 
patients with hearing loss. The 8-methyl group 
of Ile 27 8  was found to bump into Met 313  
(shown above), without any space for the side 
chains to reorient. W e concluded that this muta­
tion is serious enough to explain the observed 
phenotype, especially as the loops attached to 
helices 9 and 1 1 are involved in actin polymeri­
zation and ATP binding. Surprisingly, an actin 
orthologue in D.discoideum contains an Ile resi­
due at this position too. But in this case, a corre­
lated Thr > Ala mutation provides space for the 
larger Ile side chain.
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A mutation in the gamma actin 1 
(ACTGI) gene causes autosomal domi­
nant hearing loss
van Wijk E, Krieger E, Kemperman MH, de Leenheer EMR, Huygen PLM, Cremer
CWRJ, Cremers FPM, Kremer H 
Department of Otorhinolaryngology, UMC Nijmegen, The Netherlands
J Med Genet. (2004) 40:879-884
Abstract
Linkage analysis in a multigenerational family with autosomal dominant hearing 
loss yielded a chromosomal localization of the underlying genetic defect in the 
DFNA20/26 locus at 17q25-qter. The 6-cM critical region harbored the gamma 1 actin 
(ACTG1) gene which was considered an attractive candidate gene because actins con­
stitute important structural elements o f the inner ear hair cells. We identified a 
Thr278Ile mutation in helix 9 of the modeled protein structure. The alteration of resi­
due Thr278 is predicted to have a small but significant effect on the gamma 1 actin 
structure due to its close proximity to a methionine residue at position 313 in helix 11. 
Moreover, the Thr278 residue is highly conserved throughout eukaryotic evolution. 
Using a known actin structure the mutation could be predicted to impair actin polym­
erization. The progression of DFNA20/26 associated hearing loss is similar to 
DFNA1, DFNA17 and DFNA22 associated hearing impairment. The latter are all 
caused by mutations in genes encoding proteins functionally related to actin. The se­
verity o f the deafness in this DFNA20/26 family matches the hearing loss observed in 
(young) patients with Usher syndrome type 1 (USH1). USH1 is caused by autosomal 
recessive mutations in genes encoding proteins which are indicated to form protein 
complexes involved in stereocilia structure, cohesion and anchorage. These findings 
strongly suggest that the Thr278Ile mutation in ACTG1 represents the first disease 
causing germline mutation in a cytoplastic actin isoform.
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In a second collaboration project with Mirjam 
Luijendijk, Erwin van Wijk and Hannie Kremer, 
we built a model of myosin VIIa to analyze a 
mutation found to impair hearing. Myosin VIIa 
is expressed in the inner ear, where it was 
shown to be involved in cross-linking adjacent 
stereocilia. In the wild-type enzyme, residue Asn 
4 5 8  attaches the switch II loop to the following 
helix via two hydrogen bonds to backbone 
oxygens. One of these belongs to Phe 4 3 9  
which in turn is followed by Gly 440 . This resi­
due was found experimentally to be the central 
hinge when the myosin head domains reorient 
during the power stroke. Ile 4 5 8  disturbs this in­
teraction, indicating that myosin VIIa does not 
just play a passive structural role.
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Identification and molecular modeling of a 
mutation in the motor head domain of my­
osin VIIA in a family with autosomal domi­
nant hearing impairment (DFNAII)
Luijendijk MWJ, van W ijk  E, Krieger E, Bischoff AMLC, Cremers CWRJ, Cremers FPM, 
Kremer H, Pennings RJE, Weekamp H, Cruysberg JRM, Huygen PLM and Brunner HG
Hum Genet. (2004) in press
Abstract
Myosin VIIA is an unconventional myosin that has been implicated in Usher syn­
drome type 1B, nonsyndromic autosomal recessive hearing impairment (DFNB2) and 
autosomal dominant hearing impairment (DFNA11). Unconventional myosins are ac- 
tin-based motor molecules that transduce chemical energy derived from ATP into a 
force enabling them to move along actin filaments. The structure o f the myosin VIIA 
protein is highly conserved in vertebrates and invertebrates. Here, we present a family 
(W02-011) with nonsyndromic autosomal dominant hearing impairment that clinically 
resembles the previously published DFNA11 family. The affected family members 
from the Dutch family show a flat audiogram at young ages and only modest progres­
sion, most clear at the high frequencies Patients also suffer from minor vestibular 
symptoms. Linkage analysis indeed yielded a maximum two-point lodscore o f 3.43 for 
marker D11S937 located within 1 cM of the myosin VIIA gene. The 49 exons and 
splice sites o f the myosin VIIA gene were sequenced and 11 nucleotide variations 
were found. Ten nucleotide changes represent benign intronic variants, silent exon 
mutations or non-pathologic amino acid substitutions. One variant, a c.1373 A>T 
transversion that is heterozygously present in all affected family members and absent 
in 300 healthy individuals, results in a Asn458Ile amino acid substitution. Asn458 is 
located in a region o f the myosin VIIA motor domain that is highly conserved in dif­
ferent classes o f myosins and myosins of different species. To evaluate whether the 
Asn458Ile mutation is indeed responsible for the hearing impairment, a molecular 
model o f myosin VIIA was built based on the known structure o f the myosin II heavy 
chain from Dictyostelium discoideum. In this model, the isoleucine residue at position 
458 can’t form a hydrogen bond with phenylalanine at position 439 in the switch II 
loop and because o f its larger side chain compared to asparagine, pushes the switch II 
loop in the myosin VIIA motor domain towards the ATPase binding pocket. This 
could possibly disrupt ATP/ADP binding as well as impair the myosin power stroke, 
which would have a severe effect on the function o f the myosin VIIA protein.
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